Focal epilepsy, mode (most common among epilepsy diagnosis)

FE_MODE

partial epilepsy: A seizure caused by a localized disorder.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Check mode of ICD-10 codes: %3453, %345[4-5], %G40[0-2] Registry filters: Hospital discharge: ICD-10 — G40.0, G40.1, G40.2 Hospital discharge: ICD-9 — %345[4-5] Hospital discharge: ICD-8 — %3453 Cause of death: ICD-10 — G40.0, G40.1, G40.2 Cause of death: ICD-9 — %345[4-5] Cause of death: ICD-8 — %3453 2 out of 7 registries used, show all original rules.	8272
4. Check minimum number of events None	8272
5. Include endpoints None	8272
6. Filter based on genotype QC (FinnGen only)	8272

Control definitions (FinnGen only)

Control exclude: G6_EPLEPSY

Extra metadata

First used in FinnGen datafreeze: DF11

NAME	FE_MODE
CONTROL_EXCLUDE	G6_EPLEPSY
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	%G40[0-2]
HD_ICD_9	%345[4-5]
HD_ICD_8	%3453
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	%G40[0-2]
COD_ICD_9	%345[4-5]
COD_ICD_8	%3453
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Focal epilepsy, mode (most common among epilepsy diagnosis) based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	8272	4134	4138
Unadjusted period prevalence (%)	1.62	1.41	1.82
Median age at first event (years)	52.91	47.78	58.05

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
7436: Matched controls
74359

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

G40.9

ICD-10 Finland

Epilepsy, unspecified

3462.1

323.0

2668

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

8.0

323.0

1642

2546

183

Kela drug reimbursment

Lamotrigin and topiramate

+∞

323.0

982

N88

ICPC

Epilepsy

448.9

323.0

466

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

5.6

323.0

1316

2762

G41.9

ICD-10 Finland

Status epilepticus, unspecified

152.6

323.0

363

N03AB02

ATC

phenytoin; systemic

69.3

323.0

635

100

N03AX14

ATC

levetiracetam; systemic

300.9

323.0

2618

134

G40.10

ICD-10 Finland

Simple partial seizures

11141.9

323.0

981

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

+∞

323.0

1373

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

4503599627370496.0

323.0

2828

N05BA01

ATC

diazepam; systemic, rectal

3.8

323.0

1613

4990

R56.8

ICD-10 Finland

Other and unspecified convulsions

41.6

323.0

2694

1001

N03AX18

ATC

lacosamide; systemic

1792.5

323.0

781

G40.09

ICD-10 Finland

Other or unspecified partial (focal) idiopathic epilepsy or epileptic syndrome with local onset

+∞

323.0

397

AA1AD

NOMESCO Finland

CT of head and brain

5.2

323.0

3305

9836

XA800

NOMESCO Finland

Neuropsychological investigation

8.1

323.0

907

1248

G40.11

ICD-10 Finland

Simple partial epileptic seizure that develops into a complex partial seizure

+∞

323.0

329

N03AX09

ATC

lamotrigine; oral

9.9

323.0

1068

1240

N05BA09

ATC

clobazam; oral

576.7

323.0

636

N03AG01

ATC

valproic acid; systemic, rectal

25.4

323.0

2455

1415

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

+∞

323.0

1084

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

8633.0

323.0

785

G40.21

ICD-10 Finland

Partial epileptic seizure with cloudiness and automatism

5893.6

323.0

557

G40

ICD-10 Finland

Epilepsy

2434.5

323.0

697

G40.00

ICD-10 Finland

Benign childhood epilepsy with centrotemporal EEG spikes

3199.6

323.0

317

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

+∞

323.0

2538

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

45.5

323.0

533

126

N03AF01

ATC

carbamazepine; oral, rectal

23.8

323.0

1969

1107

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

5.7

323.0

1141

2297

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

+∞

323.0

6097

N03AF02

ATC

oxcarbazepine; oral

207.1

323.0

3123

259

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

16384.0

323.0

3149

G40.1

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

+∞

323.0

400

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

+∞

323.0

967

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

3.6

318.2

1733

5858

3454A

ICD-9 Finland

Epilepsy, Partial epilepsy, with impairment of consciousness[EPILEPSIA GENERALISATA SECUNDARIA]

+∞

313.7

299

L01AX03

ATC

temozolomide; systemic

51.7

304.6

369

G40.89

ICD-10 Finland

Other epilepsy

2843.5

295.5

284

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

9.2

288.3

633

741

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

20.0

279.6

431

228

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

12.5

275.2

513

437

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

4.4

263.0

1068

2749

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

3.9

252.5

1189

3496

N03AX11

ATC

topiramate; oral

10.1

245.3

511

541

D43.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, supratentorial

36.5

227.1

295

N05CD08

ATC

midazolam; nasal, systemic

8.9

210.6

469

556

G40.6

ICD-10 Finland

Grand mal seizures, unspecified (with or without petit mal)

1973.0

209.2

202

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

17.1

202.1

329

201

34532

ICD-8 Finland

Epilepsy, Partialis (focalis) generalisata

+∞

195.7

187

N03AE01

ATC

clonazepam; systemic

4.6

189.9

721

1709

3454B

ICD-9 Finland

Epilepsy, Partial epilepsy, with impairment of consciousness[TEMPORAALIEPILEPTINEN POISSAOLOKOHTAUS]

+∞

189.3

181

N03AX23

ATC

brivaracetam; systemic

1774.3

189.2

183

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.7

188.2

1478

6167

H02AB02

ATC

dexamethasone; systemic

3.4

186.5

1034

3408

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.6

180.8

925

2860

G40.39

ICD-10 Finland

Other or unspecified generalized epileptic syndromes with atonic, clonic, myoclonic or tonic-clonic seizures

+∞

178.8

171

N03AX15

ATC

zonisamide; oral

105.4

178.0

195

N03AX22

ATC

perampanel; oral

1846.9

177.7

172

34599

ICD-8 Finland

Epilepsy, Other and unspecified

+∞

175.7

168

34530

ICD-8 Finland

Epilepsy, Psychomotorica

+∞

174.6

167

C71.10

ICD-10 Finland

Malignant tumor in frontal lobe without histology

70.2

166.7

192

R55

ICD-10 Finland

Syncope and collapse

2.9

154.1

1061

4031

3459X

ICD-9 Finland

Epilepsy, unspecified

+∞

152.6

146

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

5.0

151.5

523

1114

AAG50

NOMESCO Finland

Stereotactic intracranial radiotherapy

35.5

150.9

197

D32.00

ICD-10 Finland

Benign tumor of the meninges on the outer surface of the cerebrum

12.4

149.6

278

232

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.4

142.7

1424

6671

K90

ICPC

Stroke/cerebrovascular accident

6.2

142.4

405

685

ZXC95

NOMESCO Finland

Use of surgical navigator

11.4

140.3

271

245

XA400

NOMESCO Finland

EEG

23.1

140.2

205

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

12.1

139.7

262

223

3451A

ICD-9 Finland

Epilepsy, Generalised convulsive epilepsy

+∞

136.9

131

7803A

ICD-9 Finland

General symptoms, Convulsions

14.6

136.6

236

167

C71.11

ICD-10 Finland

Malignant tumor of frontal lobe grade II glioma

227.3

130.3

134

I69.0

ICD-10 Finland

Sequelae of subarachnoid haemorrhage

12.9

129.7

236

188

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

15.9

127.7

213

138

N03AG04

ATC

vigabatrin; oral

+∞

127.4

122

C71.20

ICD-10 Finland

Malignant tumor in temporal lobe without histology

116.3

126.4

137

G40.0

ICD-10 Finland

Localization-related (focal)(partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset

+∞

126.4

121

I61.9

ICD-10 Finland

Intracerebral haemorrhage, unspecified

8.8

125.5

279

327

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.8

124.4

898

3481

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.9

122.9

2269

13752

AA1BD

NOMESCO Finland

Extensive CT of head and brain

5.9

122.4

362

642

T90.5

ICD-10 Finland

Sequelae of intracranial injury

11.1

121.4

237

219

G41.0

ICD-10 Finland

Grand mal status epilepticus

211.8

121.0

125

R41.0

ICD-10 Finland

Disorientation, unspecified

5.2

119.9

392

783

H53.4

ICD-10 Finland

Visual field defects

6.8

119.6

316

483

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.0

113.5

1854

10664

78020

ICD-8 Finland

Certain symptoms referable to nervous system and special senses, Convulsions

12.3

112.1

208

173

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

4.8

112.0

395

856

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

4.2

109.6

449

1129

9530/0-C70.0

ICD-O-3

Meningioma, NOS, of cerebral meninges

18.1

108.7

172

TAB00

NOMESCO Finland

Lumbar puncture

3.9

108.6

478

1283

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

8.6

108.4

245

295

130

Kela drug reimbursment

Malignant tumour

2.8

107.2

749

2832

G40.4

ICD-10 Finland

Other generalized epilepsy and epileptic syndromes

1053.3

106.6

104

A28

ICPC

Limited function/disability NOS

2.3

105.7

1174

5709

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.2

105.1

593

1940

I61.1

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, cortical

15.0

104.8

178

121

N03AF04

ATC

eslicarbazepine; oral

1032.7

104.5

102

G41.2

ICD-10 Finland

Complex partial status epilepticus

182.6

103.6

108

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

6.6

102.0

274

428

G40.3

ICD-10 Finland

Generalized idiopathic epilepsy and epileptic syndromes

+∞

101.3

C71.90

ICD-10 Finland

Malignant tumor in unspecified localization in the brain without histology

47.6

99.7

122

C71.12

ICD-10 Finland

Malignant tumor of frontal lobe grade III glioma

256.2

98.9

101

ADB00

NOMESCO Finland

Implantation of vagus nerve stimulating device

+∞

96.0

181

Kela drug reimbursment

Retigabine and vigabatrin

+∞

96.0

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

6.6

95.4

257

403

R51.80

ICD-10 Finland

Headache

2.2

95.2

1158

5843

R4150

NOMESCO Finland

Neuropsychological rehabilitation

12.9

94.9

172

136

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.8

94.3

674

2575

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

6.1

93.9

266

446

I61.0

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, subcortical

7.3

93.0

232

326

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

11.7

92.1

175

153

N18

ICPC

Paralysis/weakness

6.3

92.0

257

423

N06AB04

ATC

citalopram; systemic

1.9

91.8

1562

9012

34510

ICD-8 Finland

Epilepsy, """"Grand mal""""

+∞

90.8

YX8VG

NOMESCO Finland

Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy

34.4

85.6

112

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

3.7

85.1

403

1147

WX892

NOMESCO Finland

Monitored bed care

2.6

84.2

663

2678

XF400

NOMESCO Finland

ECG with 12 standard connections

2.0

83.7

1275

7027

R4120

NOMESCO Finland

Occupational therapy

2.8

81.1

551

2034

C71.21

ICD-10 Finland

Malignant tumor of temporal lobe grade II glioma

277.5

80.7

YX8BD

NOMESCO Finland

Stereotactic extensive CT examination for dose design of radiotherapy

22.0

80.6

119

C71.13

ICD-10 Finland

Malignant tumor of frontal lobe grade IV glioma

71.5

80.4

AAC00

NOMESCO Finland

Ligature of intracranial aneurysm

8.8

79.3

175

203

R47.0

ICD-10 Finland

Dysphasia and aphasia

9.2

78.9

170

189

SPAT1229

SPAT

Assessment of need for aid

2.6

77.6

639

2642

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.7

77.0

584

2304

N07

ICPC

Convulsion/seizure

32.3

76.9

102

S06.3

ICD-10 Finland

Focal brain injury

6.9

76.6

198

293

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.6

76.6

624

2563

S06.0

ICD-10 Finland

Concussion

2.2

75.7

839

4028

R42

ICD-10 Finland

Dizziness and giddiness

1.8

75.3

1513

9161

N05AX08

ATC

risperidone; systemic

2.4

74.6

667

2880

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

10.2

74.4

151

34539

ICD-8 Finland

Epilepsy, Partialis (focalis) NUD

+∞

74.1

R53

ICD-10 Finland

Malaise and fatigue

1.8

73.9

1454

8738

N05AH04

ATC

quetiapine; oral

1.9

73.2

1205

6800

L28

ICPC

Limited function/disability (L)

2.0

72.5

1093

5965

TPH04

NOMESCO Finland

Cathetrisation of vein

1.8

72.4

1495

9121

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

5.3

72.0

228

438

D32.02

ICD-10 Finland

Benign tumor of the meninges at the base of the brain

10.2

71.9

146

G40.30

ICD-10 Finland

Benign myoclonic eplilepsy in infancy

+∞

70.9

A06AD11

ATC

lactulose; oral

2.0

70.7

1050

5692

C71.23

ICD-10 Finland

Malignant tumor of temporal lobe grade IV glioma

48.3

70.7

I60.1

ICD-10 Finland

Subarachnoid haemorrhage from middle cerebral artery

13.9

69.9

122

W19

ICD-10 Finland

Unspecified fall

2.2

68.9

753

3585

ZXC40

NOMESCO Finland

Use of ultrasound

9.7

68.7

143

150

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.1

67.6

903

4686

3454X

ICD-9 Finland

Epilepsy, Partial epilepsy, with impairment of consciousness[ALII DISTURBATIONES CONSCIENTAE EPILEPTICI]

+∞

66.7

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.6

66.2

2905

21718

WX882

NOMESCO Finland

High dependency care

3.5

65.8

322

940

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

10.8

64.8

127

119

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

2.6

64.5

507

2033

XCK00

NOMESCO Finland

Perimetry

2.5

63.4

524

2163

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

5.8

63.0

185

325

F02.89*G40.9

ICD-10 Finland

Dementia in epilepsy

+∞

62.6

ZX050

NOMESCO Finland

Stereotactic radiotherapy

10.4

62.5

125

122

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

6.7

62.1

164

251

C71.30

ICD-10 Finland

Malignant tumor in parietal lobe without histology

87.1

62.0

D32.01

ICD-10 Finland

Benign tumor of meninges on interhemispheric surface

16.6

61.7

100

D43.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified

25.1

61.5

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

3.9

61.5

269

715

C71.22

ICD-10 Finland

Malignant tumor of temporal lobe grade III glioma

315.4

61.4

A04AA02

ATC

granisetron; systemic, transdermal

2.7

61.4

450

1733

AAG00

NOMESCO Finland

Stereotactic intracranial biopsy

28.9

61.0

N05BA04

ATC

oxazepam; oral

1.7

60.8

1658

10916

K91

ICPC

Cerebrovascular disease

6.1

60.7

172

289

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.8

60.5

1147

6755

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

4.2

58.9

235

575

C71.1

ICD-10 Finland

Malignant neoplasm: Frontal lobe

74.1

58.1

SPAT1216

SPAT

Assessment of functional ability

1.8

58.0

1053

6103

XX3DW

NOMESCO Finland

Time consuming IT work

2.1

55.7

702

3541

N28

ICPC

Limited function/disability (N)

5.2

55.6

180

355

AAF00

NOMESCO Finland

Ventriculostomy

10.1

54.8

111

C71.2

ICD-10 Finland

Malignant neoplasm: Temporal lobe

58.6

54.5

Z51.5

ICD-10 Finland

Palliative care

2.5

54.5

446

1829

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

8.1

54.1

125

157

F05.9

ICD-10 Finland

Delirium, unspecified

4.4

53.9

205

479

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

3.4

53.8

273

820

C71.99

ICD-10 Finland

Malignant tumor in unspecified localization in the brain other or unspecified histology

53.8

53.7

I60.9

ICD-10 Finland

Subarachnoid haemorrhage, unspecified

5.6

53.4

162

297

3455A

ICD-9 Finland

Epilepsy, Partial epilepsy, without mention of impairment of consciousness

+∞

53.2

A03FA01

ATC

metoclopramide; systemic, rectal

1.7

53.1

1328

8487

N02AA05

ATC

oxycodone; systemic

1.8

52.4

959

5559

34533

ICD-8 Finland

Epilepsy, Partialis (focalis) alia

+∞

52.1

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.8

51.8

1018

6041

D32.9

ICD-10 Finland

Benign neoplasm: Meninges, unspecified

12.5

51.6

AAJ20

NOMESCO Finland

Excision of epileptic focus

+∞

51.1

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.7

50.4

1126

6949

N29

ICPC

Neurological sympt/complt other

4.4

50.2

190

442

S01.0

ICD-10 Finland

Open wound of scalp

2.2

49.7

556

2657

N03AG06

ATC

tiagabine; oral

491.1

49.4

AAK00

NOMESCO Finland

Cranioplasty

37.4

49.4

C03CA01

ATC

furosemide; systemic

1.6

49.3

1804

12703

N02BE01

ATC

paracetamol; systemic, rectal

1.5

49.1

5821

52250

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

4.4

49.1

184

424

TKC20

NOMESCO Finland

Catheterisation of bladder

2.2

48.1

524

2475

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.9

47.9

733

3980

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.3

47.5

485

2221

PA2CC

NOMESCO Finland

Cerebral very extensive angiography with X-ray

7.7

47.5

113

149

9440/3-C71.9

ICD-O-3

Glioblastoma, NOS, of brain, NOS

67.9

47.1

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.1

47.0

595

2997

A86

ICD-10 Finland

Unspecified viral encephalitis

13.1

46.2

D43.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, unspecified

29.7

46.1

N06AX11

ATC

mirtazapine; oral

1.5

46.1

1999

14593

C71.29

ICD-10 Finland

Malignant tumor in temporal lobe other or unspecified histology

85.6

45.9

R4130

NOMESCO Finland

Speech therapy

3.6

45.8

215

607

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.6

45.7

341

1325

S06.2

ICD-10 Finland

Diffuse brain injury

6.1

45.7

128

213

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.4

45.5

410

1767

WF002

NOMESCO Finland

Radical radiotherapy

2.5

45.3

370

1514

PA7CD

NOMESCO Finland

CT angiography of neck and brain, extensive

5.7

45.0

133

237

3453A

ICD-9 Finland

Epilepsy, Grand mal status

+∞

44.8

B01AA03

ATC

warfarin; systemic

1.6

44.5

1284

8488

R40.2

ICD-10 Finland

Coma, unspecified

7.1

44.4

111

158

WX872

NOMESCO Finland

Intensive care

2.4

44.2

384

1623

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

5.4

43.9

135

252

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.8

43.8

845

4965

G40.51

ICD-10 Finland

Epileptic seizures related to alcohol

+∞

43.8

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

43.7

1375

9289

WX730

NOMESCO Finland

Conventional respirator

4.3

43.5

169

404

N03AX12

ATC

gabapentin; oral

1.7

43.2

969

5962

AA5PD

NOMESCO Finland

CT examination of brain pefusion

7.6

43.0

103

138

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

42.8

1222

8043

AA5FG

NOMESCO Finland

Functional MRI examination of brain with high intensity magnet

150.9

42.8

N05CF01

ATC

zopiclone; oral

1.5

42.8

2015

14922

P20

ICPC

Memory disturbance

1.8

42.5

743

4223

N06AB10

ATC

escitalopram; oral

1.6

42.2

1263

8415

SPAT1254

SPAT

Administration of medicine

1.7

42.1

1030

6498

C71.19

ICD-10 Finland

Malignant tumor of frontal lobe other or unspecified histology

68.9

42.0

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.0

41.7

599

3170

N05AH03

ATC

olanzapine; systemic

2.3

41.5

422

1929

F70.0

ICD-10 Finland

Mild mental retardation, With the statement of no, or minimal, impairment of behaviour

11.8

41.3

N05CD07

ATC

temazepam; oral

1.8

41.3

799

4693

SPAT1234

SPAT

Support of social functional capacity

2.4

41.2

377

1636

G40.7

ICD-10 Finland

Petit mal, unspecified, without grand mal seizures

409.8

41.2

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.4

41.0

366

1566

G91.0

ICD-10 Finland

Communicating hydrocephalus

9.2

40.9

G41.8

ICD-10 Finland

Other status epilepticus

49.3

40.7

PA2BC

NOMESCO Finland

Cerebral extensive angiography with X-ray

5.8

40.6

118

206

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.0

40.4

592

3156

B01AC04

ATC

clopidogrel; oral

1.7

40.2

961

6020

R1260

NOMESCO Finland

Evaluation of communicative skills

4.0

40.1

165

417

AAJ99

NOMESCO Finland

Other operation for epilepsy

+∞

39.6

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

39.5

881

5404

G81.9

ICD-10 Finland

Hemiplegia, unspecified

5.5

39.3

120

223

N19

ICPC

Speech disorder

4.2

39.2

152

364

SPAT1301

SPAT

No procedures

1.4

39.0

2072

15660

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

10.0

39.0

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.0

38.9

519

2666

C71.00

ICD-10 Finland

Malignant tumor of the cerebrum except lobes and ventricles without histology

51.4

38.5

PA7BD

NOMESCO Finland

CT angiography of neck and brain

4.1

38.4

156

390

N76

ICPC

Neoplasm nervous system unspecified

56.6

38.3

AA5DR

NOMESCO Finland

Brain metabolism PET with CT

19.5

38.2

N99

ICPC

Neurological disease other

5.1

38.2

123

243

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.8

38.2

256

932

D32.0

ICD-10 Finland

Benign neoplasm: Cerebral meninges

15.6

37.7

Q28.2

ICD-10 Finland

Arteriovenous malformation of cerebral vessels

14.3

37.6

34598

ICD-8 Finland

Epilepsy, Alia definita

+∞

37.5

C71.33

ICD-10 Finland

Malignant tumor of parietal lobe grade IV glioma

61.7

37.1

C71.31

ICD-10 Finland

Malignant tumor of the parietal lobe grand II glioma

369.2

37.0

I63.0

ICD-10 Finland

Cerebral infarction due to thrombosis of precerebral arteries

4.4

37.0

139

323

G80.2

ICD-10 Finland

Spastic hemiplegic cerebral palsy

29.0

36.4

AEA50

NOMESCO Finland

Adjustment of implanted neurostimulator

9.8

36.3

R50.9

ICD-10 Finland

Fever, unspecified

1.6

35.8

935

5987

WF003

NOMESCO Finland

Adjuvant radiotherapy

2.8

35.8

243

894

G40.80

ICD-10 Finland

Epilepsy with continuous EEG spike-waves during slow wave sleep

+∞

35.4

G40.8

ICD-10 Finland

Other epilepsy

+∞

35.4

R90.8

ICD-10 Finland

Other abnormal findings on diagnostic imaging of central nervous system

5.7

35.2

103

182

R1250

NOMESCO Finland

Evaluation of functional capability

3.4

34.5

176

533

9400/3-C71.9

ICD-O-3

Astrocytoma, NOS, of brain, NOS

175.8

33.7

A02BC02

ATC

pantoprazole; systemic

1.3

33.6

4067

35134

R11

ICD-10 Finland

Nausea and vomiting

1.9

33.4

528

2890

34519

ICD-8 Finland

Epilepsy, Generalisata convulsiva NUD

+∞

33.3

R56.0

ICD-10 Finland

Febrile convulsions

8.1

33.3

N03AX16

ATC

pregabalin; oral

1.5

32.9

1397

10031

M03BX01

ATC

baclofen; systemic

3.7

32.9

149

411

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.9

32.8

523

2871

AAJ15

NOMESCO Finland

Hippocampectomy

+∞

32.3

9400/3-C71.1

ICD-O-3

Astrocytoma, NOS, of frontal lobe

318.4

31.9

N05AA02

ATC

levomepromazine; systemic

2.4

31.3

286

1241

D33.00

ICD-10 Finland

Medial pilosytic astrocytoma of the cerebrum

21.0

31.2

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

2.5

31.1

247

994

WX408

NOMESCO Finland

General anesthesy, balanced

1.4

30.7

1686

12712

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

30.6

1704

12882

N74

ICPC

Malignant neoplasm nervous system

26.4

30.5

G40.59

ICD-10 Finland

Other special epileptic syndromes

+∞

30.2

R4110

NOMESCO Finland

Physiotherapy

1.4

30.0

1603

12021

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

29.9

1261

9018

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.7

29.7

729

4574

AAA35

NOMESCO Finland

Insertion of subdural electrodes

+∞

29.2

SPAT1231

SPAT

Assessment of adjustments needed in living environment

3.1

29.1

162

525

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.4

28.7

255

1093

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.9

28.6

427

2286

H47.2

ICD-10 Finland

Optic atrophy

8.7

28.6

R41.3

ICD-10 Finland

Other amnesia

2.8

28.5

194

714

SPAT1053

SPAT

Memory test

1.6

28.4

846

5581

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.8

28.4

537

3116

I63.8

ICD-10 Finland

Other cerebral infarction

5.5

28.3

156

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

2.9

28.2

180

638

S06.6

ICD-10 Finland

Traumatic subarachnoid haemorrhage

4.6

28.1

213

9440/3-C71.1

ICD-O-3

Glioblastoma, NOS, of frontal lobe

39.1

28.0

F80.1

ICD-10 Finland

Expressive language disorder

4.6

27.9

214

B01AC07

ATC

dipyridamole; systemic

2.1

27.8

316

1520

SPAT1245

SPAT

Provision of support and information to patient’s family members

2.2

27.8

287

1323

C71.3

ICD-10 Finland

Malignant neoplasm: Parietal lobe

282.5

27.8

AAD05

NOMESCO Finland

Evacuation of acute subdural haematoma

8.9

27.6

N05AD01

ATC

haloperidol; systemic

2.5

27.4

216

869

4380A

ICD-9 Finland

Late effects of cerebrovascular disease[SEQUELAE MORBI CEREBROVASCULARIS]

7.3

27.3

A04AA01

ATC

ondansetron; systemic, rectal

1.9

27.3

406

2171

4300A

ICD-9 Finland

Subarachnoid haemorrhage[HAEMORRHAGIA SUBARACHNOID. POST ANEURYSMA SACCULARE]

8.0

27.2

G91.1

ICD-10 Finland

Obstructive hydrocephalus

8.0

27.2

34500

ICD-8 Finland

Epilepsy, """"Petit mal""""

+∞

27.1

3450A

ICD-9 Finland

Epilepsy, Generalised nonconvulsive epilepsy

+∞

27.1

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.1

27.0

303

1448

I69.8

ICD-10 Finland

Sequelae of other and unspecified cerebrovascular diseases

8.5

26.9

WF049

NOMESCO Finland

Radiotherapy of metastasis

2.5

26.7

211

851

9440/3-C71.2

ICD-O-3

Glioblastoma, NOS, of temporal lobe

27.8

26.6

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.5

26.6

127

367

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.2

26.6

270

1232

XX1XW

NOMESCO Finland

Extensive written report from radiologist

3.0

26.6

161

553

2152

FHL

Extraction, big brain

19.1

26.4

AAB30

NOMESCO Finland

Evacuation of spontaneous intracranial haematoma

19.1

26.4

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.9

26.4

405

2192

F79.0

ICD-10 Finland

Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour

11.5

26.3

Q85.1

ICD-10 Finland

Tuberous sclerosis

51.8

26.2

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.3

26.0

254

1141

G41.1

ICD-10 Finland

Petit mal status epilepticus

40.2

25.8

R25.2

ICD-10 Finland

Cramp and spasm

2.9

25.8

165

586

G80.1

ICD-10 Finland

Spastic diplegic cerebral palsy

24.1

25.6

N05BA06

ATC

lorazepam; systemic, sublingual

2.0

25.5

317

1583

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.3

25.4

254

1150

N30.0

ICD-10 Finland

Acute cystitis

1.6

25.3

786

5237

9530/0-C70.9

ICD-O-3

Meningioma, NOS, of meninges, NOS

12.6

25.2

SPAT1240

SPAT

Therapeutic discussion

1.6

25.2

652

4147

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.3

25.1

2003

16002

Q28.3

ICD-10 Finland

Other malformations of cerebral vessels

8.0

25.0

G40.50

ICD-10 Finland

Epilepsia partialis continua [Kozhevnikof]

+∞

25.0

G04.9

ICD-10 Finland

Encephalitis, myelitis and encephalomyelitis, unspecified

9.5

24.9

D33.05

ICD-10 Finland

Other lateral benign tumor in temporal lobe

70.1

24.8

TPH07

NOMESCO Finland

Cathetrisation of artery

1.6

24.7

615

3872

C71.32

ICD-10 Finland

Malignant tumor of parietal lobe grade III glioma

130.4

24.6

9450/3-C71.1

ICD-O-3

Oligodendroglioma, NOS, of frontal lobe

130.4

24.6

S42.2

ICD-10 Finland

Fracture of upper end of humerus

2.1

24.6

279

1342

AAD10

NOMESCO Finland

Evacuation of chronic subdural haematoma

3.7

24.4

109

299

F83

ICD-10 Finland

Mixed specific developmental disorders

4.9

24.3

164

A04

ICPC

Weakness/tiredness general

1.5

24.3

780

5233

YA1VG

NOMESCO Finland

MRI examination of head and neck with high intesity magnet for dose design of radiotherapy

8.0

24.3

G81.1

ICD-10 Finland

Spastic hemiplegia

14.9

24.2

D43.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, infratentorial

13.7

24.0

AAK80

NOMESCO Finland

Partial excision of skull cap

37.7

23.9

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.0

23.8

320

1649

2161

FHL

Neck ligation, big brain

7.5

23.7

AAC40

NOMESCO Finland

Extirpation of intracranial arterio-venous malformation

31.1

23.7

C71.01

ICD-10 Finland

Malignant tumor of cerebellum except lobes and ventricles grade II glioma

240.7

23.6

H03AA01

ATC

levothyroxine sodium; systemic

1.4

23.6

1293

9684

C08CA01

ATC

amlodipine; oral

1.3

23.5

2003

16125

WX110

NOMESCO Finland

Local anesthesy

1.3

23.5

4405

39471

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.5

23.3

1024

7348

H02AB09

ATC

hydrocortisone; systemic

2.6

23.3

178

703

RS222

NOMESCO Finland

3.4

23.0

112

330

ZXM40

NOMESCO Finland

Use of fluorescent substance

18.5

23.0

I63.1

ICD-10 Finland

Cerebral infarction due to embolism of precerebral arteries

3.9

22.8

241

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.8

22.6

433

2522

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

22.5

1772

14078

ICD-10 Finland

2.6

22.5

171

675

AAD15

NOMESCO Finland

Evacuation of traumatic intracerebral haematoma

22.9

22.5

F06.9

ICD-10 Finland

Unspecified mental disorder due to brain damage and dysfunction and to physical disease

9.8

22.4

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

2.7

22.4

154

572

H53.2

ICD-10 Finland

Diplopia

2.4

22.4

190

797

Z02.4

ICD-10 Finland

Examination for driving licence

0.7

22.3

708

9983

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

2.5

22.2

175

704

AAA27

NOMESCO Finland

Insertion of intracerebral pressure monitoring device

16.7

22.2

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.0

22.1

283

1429

G72.8

ICD-10 Finland

Other specified myopathies

3.2

22.1

117

368

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

2.2

22.0

226

1039

S18

ICPC

Laceration/cut

1.3

22.0

2480

20736

F03

ICD-10 Finland

Unspecified dementia

2.1

21.9

250

1206

G40.01

ICD-10 Finland

Pediatric epilepsy with occipital EEG paroxysms

+∞

21.9

SPAT1224

SPAT

Implementation of speech therapy rehabilitation plan

3.1

21.8

125

414

G05.1*B00.4

ICD-10 Finland

Herpesviral meningoencephalitis

38.7

21.7

F71.0

ICD-10 Finland

Moderate mental retardation, with the statement of no, or minimal, impairment of behaviour

31.2

21.4

S22.3

ICD-10 Finland

Fracture of rib

1.8

21.4

383

2183

I67.6

ICD-10 Finland

Nonpyogenic thrombosis of intracranial venous system

10.6

21.3

Q04.8

ICD-10 Finland

Other specified congenital malformations of brain

28.1

20.9

N03AD01

ATC

ethosuximide; oral

+∞

20.8

A29

ICPC

General symptom/complaint other

1.6

20.8

634

4193

XX1FW

NOMESCO Finland

Written report from MRI examination performed elsewhere

24.2

20.8

SPAT1252

SPAT

Overall medication plan or its review

1.7

20.7

412

2428

PA2AD

NOMESCO Finland

CT angiography of brain

5.5

20.6

112

AAU00

NOMESCO Finland

Removal of implant or external fixation device from skull

110.3

20.6

AWB00

NOMESCO Finland

Reoperation for superficial infection in surgery of the nervous system

10.3

20.5

Z75.5

ICD-10 Finland

Holiday relief care

4.5

20.5

164

G93.0

ICD-10 Finland

Cerebral cysts

6.5

20.4

N03AA02

ATC

phenobarbital; systemic

25.5

20.4

G45.4

ICD-10 Finland

Transient global amnesia

2.6

20.4

146

558

E87.6

ICD-10 Finland

Hypokalaemia

2.4

20.3

182

785

D21

ICPC

Swallowing problem

3.3

20.3

102

309

N80

ICPC

Head injury other

2.8

20.3

129

459

U04

ICPC

Incontinence urine

2.0

20.3

262

1330

N06AX16

ATC

venlafaxine; oral

1.5

20.3

741

5110

N05AD03

ATC

melperone; systemic

3.4

20.2

294

I60.0

ICD-10 Finland

Subarachnoid haemorrhage from carotid siphon and bifurcation

7.8

20.2

WX704

NOMESCO Finland

Intubation

1.7

20.1

417

2492

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.7

20.0

475

2946

R25.1

ICD-10 Finland

Tremor, unspecified

2.4

19.9

177

761

AWC00

NOMESCO Finland

Reoperation of nervous system because of deep wound infection in the nervous system

18.8

19.9

9450/3-C71.9

ICD-O-3

Oligodendroglioma, NOS, of brain, NOS

+∞

19.8

F05.8

ICD-10 Finland

Other delirium

5.0

19.8

130

WYA20

NOMESCO Finland

Home visit

3.0

19.7

115

388

GBB00

NOMESCO Finland

Tracheostomy

3.5

19.5

261

F44.5

ICD-10 Finland

Dissociative convulsions

40.2

19.5

RS221

NOMESCO Finland

2.9

19.5

118

407

D32.04

ICD-10 Finland

Secondary or multiple benign tumor of the meninges above the exam

19.4

19.5

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.5

19.4

606

4035

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.0

19.3

257

1320

I69.2

ICD-10 Finland

Sequelae of other nontraumatic intracranial haemorrhage

12.6

19.3

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

3.1

19.3

108

355

C07AB07

ATC

bisoprolol; oral

1.3

19.2

2708

23181

D33.08

ICD-10 Finland

Another benign tumor of the cerebral ventricle

31.3

19.2

ZSA00

NOMESCO Finland

Procedure related to previous procedure classified in chapter A

6.8

19.2

3431A

ICD-9 Finland

Infantile cerebral palsy, Hemiplegic

46.1

19.2

Z00.0

ICD-10 Finland

General medical examination

1.4

19.2

1076

8062

I61.8

ICD-10 Finland

Other intracerebral haemorrhage

11.0

19.1

G06.0

ICD-10 Finland

Intracranial abscess and granuloma

16.7

19.1

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

3.2

19.0

309

G91.9

ICD-10 Finland

Hydrocephalus, unspecified

5.7

18.9

C71.40

ICD-10 Finland

Malignant tumor of the occipital lobe without histology

55.1

18.9

V700A

ICD-9 Finland

General medical examination, Routine general medical examination at a health care facility

2.4

18.9

169

728

W10

ICD-10 Finland

Fall on and from stairs and steps

1.9

18.9

282

1511

G04.8

ICD-10 Finland

Other encephalitis, myelitis and encephalomyelitis

34.4

18.9

N05AB03

ATC

perphenazine; systemic, rectal

2.1

18.8

213

1026

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

3.8

18.8

213

9401/3-C71.9

ICD-O-3

Astrocytoma, anaplastic, NOS, of brain, NOS

+∞

18.8

I60.8

ICD-10 Finland

Other subarachnoid haemorrhage

11.8

18.7

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.5

18.7

779

5518

9440/3-C71.3

ICD-O-3

Glioblastoma, NOS, of parietal lobe

190.4

18.5

I95.1

ICD-10 Finland

Orthostatic hypotension

2.1

18.5

206

984

AAA10

NOMESCO Finland

Biopsy through craniotomy

14.1

18.5

I62.0

ICD-10 Finland

Nontraumatic subdural haemorrhage

4.5

18.5

149

AA7AA

NOMESCO Finland

Liquor cerebri shunt X-ray examinatin without contrast

7.8

18.5

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.5

18.4

789

5622

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

18.4

421

2588

S72.0

ICD-10 Finland

Fracture of neck of femur

2.1

18.3

221

1092

Y0209

ICD-8 Finland

Examination of the nervous system and sensory organs, Nervous system

4.6

18.3

137

G43.9

ICD-10 Finland

Migraine, unspecified

1.8

18.2

300

1663

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

3.3

18.1

277

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.3

18.1

1614

12997

F70.9

ICD-10 Finland

Mild mental retardation, Without mention of impairment of behaviour

13.0

17.9

A41.9

ICD-10 Finland

Sepsis, unspecified

2.0

17.8

221

1105

XXA00

NOMESCO Finland

Clinical examination requiring general anaesthesia

4.8

17.8

124

I60.7

ICD-10 Finland

Subarachnoid haemorrhage from intracranial artery, unspecified

7.1

17.7

JN4BD

NOMESCO Finland

Extensive body CT

1.5

17.7

593

4007

G40.33

ICD-10 Finland

Juvenile absence epilepsy

+∞

17.7

AAJ10

NOMESCO Finland

Lobectomy for epilepsy

+∞

17.7

34531

ICD-8 Finland

Epilepsy, Patrialis (focalis) Jackson

+∞

17.7

C71.39

ICD-10 Finland

Malignant tumor of parietal lobe other or unspecified histology

66.7

17.7

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

3.5

17.7

245

F70.1

ICD-10 Finland

Mild mental retardation, Significant impairment of behaviour requiring attention or treatment

11.0

17.7

OAA67

SPAT

0.5

17.6

118

2449

X58

ICD-10 Finland

Exposure to other specified factors

1.4

17.6

784

5627

CS424

NOMESCO Finland

Visual field testing with Goldmann perimetry

4.2

17.5

162

G44.2

ICD-10 Finland

Tension-type headache

1.5

17.5

701

4925

D32.03

ICD-10 Finland

Benign meningioma in ventricles

13.1

17.4

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

2.1

17.3

204

998

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.6

17.3

477

3078

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.5

17.3

574

3872

R90.0

ICD-10 Finland

Intracranial space-occupying lesion

11.1

17.2

B01AB05

ATC

enoxaparin; parenteral

1.3

17.1

1670

13597

T85.0

ICD-10 Finland

Mechanical complication of ventricular intracranial (communicating) shunt

10.4

17.1

J01EA01

ATC

trimethoprim; systemic

1.3

17.1

1373

10875

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

2.5

17.0

136

556

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.8

16.9

291

1640

C10AA01

ATC

simvastatin; oral

1.3

16.8

2396

20451

F06.8

ICD-10 Finland

Other specified mental disorders due to brain damage and dysfunction and to physical disease

14.0

16.7

9451/3-C71.1

ICD-O-3

Oligodendroglioma, anaplastic, NOS, of frontal lobe

+∞

16.7

7819X

ICD-9 Finland

Symptoms involving nervous and musculoskeletal systems, Other symptoms involving nervous and musculoskeletal systems[SYMPTOMATA ALIA SYSTEMATIS NERVORUM ET MUSCULOSCEL]

3.7

16.7

200

Z50.5

ICD-10 Finland

Speech therapy

2.7

16.6

116

439

9380/3-C71.9

ICD-O-3

Glioma, malignant of brain, NOS

90.3

16.6

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.7

16.5

356

2152

AA5FK

NOMESCO Finland

Functional assessment (fMRI) of brain

170.3

16.5

R47.1

ICD-10 Finland

Dysarthria and anarthria

3.9

16.5

177

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

2.0

16.5

226

1176

EBA00

NOMESCO Finland

Extraction of tooth

1.3

16.4

1943

16203

R40.0

ICD-10 Finland

Somnolence

6.8

16.4

N05BA12

ATC

alprazolam; oral

1.5

16.4

542

3649

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

2.6

16.3

117

449

R60.0

ICD-10 Finland

Localized oedema

1.5

16.3

580

3971

N06DA03

ATC

rivastigmine; oral, transdermal

2.0

16.2

199

993

D32.07

ICD-10 Finland

Secondary or multiple benign tumor of the meninges below the exam

15.3

16.1

R46.8

ICD-10 Finland

Other symptoms and signs involving appearance and behaviour

9.7

16.1

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

3.6

16.0

207

RS122

NOMESCO Finland

7.9

16.0

R47.8

ICD-10 Finland

Other and unspecified speech disturbances

3.7

16.0

187

PA3AC

NOMESCO Finland

Carotis angiography with X-ray

6.7

16.0

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.7

15.9

303

1765

J01DB01

ATC

cefalexin; oral

1.2

15.9

5351

50036

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

3.5

15.8

209

N05AF03

ATC

chlorprothixene; systemic

2.2

15.8

155

703

G43.3

ICD-10 Finland

Complicated migraine

2.9

15.8

318

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.4

15.8

740

5359

C71.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of brain

60.1

15.7

C07AA05

ATC

propranolol; systemic

1.4

15.7

1029

7894

M01AH05

ATC

etoricoxib; oral

0.8

15.7

2658

30194

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

15.7

1838

15299

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.3

15.6

145

639

G40.35

ICD-10 Finland

Juvenile absence epilepsy

+∞

15.6

AA11X

NOMESCO Finland

+∞

15.6

3458X

ICD-9 Finland

Epilepsy, Other forms of epilepsy

+∞

15.6

G40.36

ICD-10 Finland

Juvenile myoclonic epilepsy [impulsive petit mal]

+∞

15.6

34509

ICD-8 Finland

Epilepsy, Absentia epileptica NUD

+∞

15.6

AAA40

NOMESCO Finland

Insertion of intracerebral electrodes

+∞

15.6

7840A

ICD-9 Finland

Symptoms involving head and neck, Headache

3.4

15.6

227

9531/0-C70.0

ICD-O-3

Meningothelial meningioma of cerebral meninges

17.2

15.6

OAB43

SPAT

0.7

15.5

454

6521

F06.32

ICD-10 Finland

Organic depression

8.9

15.4

AAF25

NOMESCO Finland

Removal of shunt of ventricle of brain

8.9

15.4

N06DX01

ATC

memantine; oral

1.7

15.4

314

1868

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.6

15.3

441

2875

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

4.7

15.2

109

I63.5

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries

2.9

15.2

315

P29

ICPC

Psychological sympt/compl other

1.7

15.2

314

1873

N05CD02

ATC

nitrazepam; oral

2.6

15.2

110

425

34300

ICD-8 Finland

Cerebral spastic infantile paralysis, Hemiplegia spastica

28.6

15.2

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.5

15.1

625

4412

H53.1

ICD-10 Finland

Subjective visual disturbances

1.7

15.1

327

1978

G80.9

ICD-10 Finland

Cerebral palsy, unspecified

23.4

15.1

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

1.8

15.1

283

1641

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

5.5

15.0

N06AB06

ATC

sertraline; oral

1.5

15.0

574

3990

WZC30

NOMESCO Finland

Teaching

1.4

14.9

712

5175

S06.4

ICD-10 Finland

Epidural haemorrhage

7.6

14.8

B94.1

ICD-10 Finland

Sequelae of viral encephalitis

56.8

14.8

S02.00

ICD-10 Finland

Fracture of the upper part of the head closed

6.0

14.8

F10.09

ICD-10 Finland

Alcohol intoxication UNS

2.3

14.7

133

579

D33.02

ICD-10 Finland

Another benign medial tumor of the cerebrum

18.4

14.7

PA2AC

NOMESCO Finland

Cerebral angiography with X-ray

6.1

14.6

N75

ICPC

Benign neoplasm nervous system

21.0

14.6

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

14.6

603

4258

3457B

ICD-9 Finland

Epilepsy, Epilepsia partialis continua[EPILEPSIA PARTIALIS CONTINUA]

+∞

14.6

9382/3-C71.1

ICD-O-3

Oligoastrocytoma, NOS, of frontal lobe

+∞

14.6

I63.2

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries

3.4

14.6

213

96610

ICD-8 Finland

Adverse effect of anticonvulsants, Hydantoin derivatives

80.2

14.6

ZXA00

NOMESCO Finland

Right side

1.3

14.5

1485

12133

C71.82

ICD-10 Finland

Overall malignant tumor of the brain grade III glioma

150.3

14.5

2151

FHL

Resection, big brain

36.1

14.4

I61

ICD-10 Finland

Intracerebral haemorrhage

10.0

14.4

AA1AA

NOMESCO Finland

Head X-ray examination

3.5

14.4

194

OAB48

SPAT

0.6

14.4

175

3043

S06.9

ICD-10 Finland

Intracranial injury, unspecified

4.2

14.4

130

TAA40

NOMESCO Finland

Cathetrisation of cerebrospinal fluid through skin

7.5

14.3

P85

ICPC

Mental retardation

7.8

14.3

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.6

14.3

334

2068

9694A

ICD-9 Finland

Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers

4.6

14.3

108

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.6

14.2

340

2117

113

Kela drug reimbursment

Anxiety disorders associated with mental retardation

8.2

14.2

N30.9

ICD-10 Finland

Cystitis, unspecified

1.7

14.2

293

1750

S02.11

ICD-10 Finland

Fracture of base of skull, open

5.7

14.1

Y86

ICD-10 Finland

Sequelae of other accidents

5.7

14.1

N06AX03

ATC

mianserin; oral

1.8

14.1

262

1513

S70.0

ICD-10 Finland

Contusion of hip

2.0

14.1

189

978

G30.8

ICD-10 Finland

Other Alzheimer disease

2.4

14.1

117

488

2250A

ICD-9 Finland

Benign neoplasm of brain and other parts of nervous system, Brain

42.5

14.1

F10.25

ICD-10 Finland

Alcohol dependence continuous use

2.5

14.1

110

444

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.4

14.0

733

5410

E87.0

ICD-10 Finland

Hyperosmolality and hypernatraemia

5.8

14.0

F07.9

ICD-10 Finland

Unspecified organic personality and behavioural disorder due to brain disease, damage and dysfunction

10.9

14.0

43090

ICD-8 Finland

Subarachnoid haemorrhage, Postaneurysma sacculare, hypertonia non indicata

8.4

14.0

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.4

14.0

114

474

F10.20

ICD-10 Finland

Alcohol dependence currently independent

2.4

13.9

119

505

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.5

13.9

566

3986

F07.8

ICD-10 Finland

Other organic personality and behavioural disorders due to brain disease, damage and dysfunction

15.8

13.9

N07BB01

ATC

disulfiram; oral

1.8

13.9

240

1358

9537/0-C70.0

ICD-O-3

Transitional meningioma of cerebral meninges

30.1

13.9

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

2.4

13.8

115

481

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.5

13.8

513

3548

F06.30

ICD-10 Finland

Organic manic syndrome

20.0

13.7

SPAT1260

SPAT

Consultation of another employee

1.3

13.7

983

7634

I60.2

ICD-10 Finland

Subarachnoid haemorrhage from anterior communicating artery

4.8

13.7

ZXA05

NOMESCO Finland

Left side

1.3

13.7

1389

11321

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

3.7

13.7

156

F01.9

ICD-10 Finland

Vascular dementia, unspecified

2.8

13.7

302

C02AC05

ATC

moxonidine; oral

1.8

13.6

238

1353

SPAT1101

SPAT

Orthostatic test

1.8

13.6

239

1357

SPAT1249

SPAT

Treatment-related counselling outside office

1.2

13.6

2340

20273

PA2VT

NOMESCO Finland

Intravascular evacuation of brain artery embolus

5.1

13.6

AAF15

NOMESCO Finland

Ventriculoatrial shunt

6.9

13.6

9401/3-C71.2

ICD-O-3

Astrocytoma, anaplastic, NOS, of temporal lobe

+∞

13.5

XX9WW

NOMESCO Finland

+∞

13.5

9400/3-C71.2

ICD-O-3

Astrocytoma, NOS, of temporal lobe

+∞

13.5

F43.29

ICD-10 Finland

Adaptation disorder UNS

2.3

13.5

119

511

C71.83

ICD-10 Finland

Overall malignant tumor of the brain grade IV glioma

34.1

13.5

C71.80

ICD-10 Finland

Overall malignant tumor of the brain without histology

34.1

13.5

SPAT1210

SPAT

Application of cast or individual aid

1.8

13.5

231

1305

G40.52

ICD-10 Finland

Epileptic seizures related to drugs

140.2

13.4

FPK00

NOMESCO Finland

Implantation of electrocardiograph with loop recorder

4.5

13.4

106

PA2LT

NOMESCO Finland

Endovascular closure of extensive brain aneurysm

5.8

13.4

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.7

13.4

273

1627

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

13.4

1460

12008

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

2.0

13.3

163

813

SPAT1153

SPAT

Removal of sutures

1.2

13.3

1769

14889

C09AA05

ATC

ramipril; oral

1.3

13.3

1314

10668

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

2.8

13.3

308

SPAT1251

SPAT

Organisation of medication

1.8

13.3

210

1155

I10

ICD-10 Finland

Essential (primary) hypertension

1.2

13.2

3247

29123

S72.1

ICD-10 Finland

Pertrochanteric fracture

2.3

13.2

121

534

PA6AD

NOMESCO Finland

CT of neck arteries

3.0

13.2

247

F10.24

ICD-10 Finland

Alcohol depence active use

2.7

13.1

338

D64.9

ICD-10 Finland

Anaemia, unspecified

1.5

13.1

528

3709

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

1.8

13.1

215

1197

R33

ICD-10 Finland

Retention of urine

1.5

13.0

414

2763

N05AH02

ATC

clozapine; systemic

2.3

13.0

114

492

I67.9

ICD-10 Finland

Cerebrovascular disease, unspecified

3.4

13.0

184

A07

ICPC

Coma

6.2

13.0

F10.41

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol with seizures

7.3

12.9

N05AX12

ATC

aripiprazole; systemic

1.9

12.9

199

1083

D42.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Cerebral meninges

19.0

12.9

RS340

NOMESCO Finland

6.4

12.9

NB6AA

NOMESCO Finland

Humerus X-ray examination

2.3

12.8

112

481

A46

ICD-10 Finland

Erysipelas

1.4

12.8

731

5477

U07.2

ICD-10 Finland

COVID-19, virus not identified

0.7

12.8

507

6922

D33.9

ICD-10 Finland

Benign neoplasm: Central nervous system, unspecified

11.5

12.8

FP1B5

NOMESCO Finland

Resting ECG, 12 leads

2.6

12.6

367

K59.0

ICD-10 Finland

Constipation

1.6

12.6

299

1856

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.3

12.6

956

7484

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.7

12.6

269

1624

9401/3-C71.1

ICD-O-3

Astrocytoma, anaplastic, NOS, of frontal lobe

70.0

12.6

F79.9

ICD-10 Finland

Unspecified mental retardation, without mention of impairment of behaviour

12.3

12.6

ZX095

NOMESCO Finland

Combined chemoradiotherapy

3.8

12.5

138

N05BA02

ATC

chlordiazepoxide; systemic

2.1

12.5

139

669

SPAT1104

SPAT

Monitoring of emergency patient

1.6

12.5

358

2332

2174

FHL

Delete a block

+∞

12.5

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.0

12.5

152

759

R56

ICD-10 Finland

Convulsions, not elsewhere classified

24.3

12.4

PA7ST

NOMESCO Finland

Extensive medical infusion to cerebral artery

24.3

12.4

F00.00*G30.0

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms

4.2

12.4

110

2132

FHL

Ventricular operators sunt

20.0

12.4

C79.31

ICD-10 Finland

Secondary malignant tumor of the cerebellum

6.8

12.3

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

2.7

12.3

305

G30.0

ICD-10 Finland

Alzheimer disease with early onset

3.4

12.3

171

R13

ICD-10 Finland

Dysphagia

1.6

12.3

323

2062

4340A

ICD-9 Finland

Occlusion of cerebral arteries, Cerebral thrombosis

3.1

12.3

209

WF004

NOMESCO Finland

Palliative radiotherapy

2.4

12.2

105

448

PA2BG

NOMESCO Finland

MRI examination of vessels in the head with high intensity magnet

4.0

12.2

117

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

3.1

12.2

216

SPAT1263

SPAT

Sampling

1.2

12.2

2521

22189

Z71.8

ICD-10 Finland

Other specified counselling

1.3

12.1

1304

10696

RS121

NOMESCO Finland

3.5

12.1

158

G30.1

ICD-10 Finland

Alzheimer disease with late onset

1.7

12.1

269

1646

XX3XW

NOMESCO Finland

3.9

12.1

123

N06DA02

ATC

donepezil; oral

1.7

12.0

265

1617

2252A

ICD-9 Finland

Benign neoplasm of brain and other parts of nervous system, Cerebral meninges

21.3

12.0

Z63.7

ICD-10 Finland

Other stressful life events affecting family and household

2.3

12.0

104

448

F07.2

ICD-10 Finland

Postconcussional syndrome

10.0

12.0

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.7

12.0

230

1349

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.3

11.9

1028

8188

J01CA08

ATC

pivmecillinam; oral

1.2

11.9

2031

17525

SPAT1050

SPAT

Extensive neurological examination

2.1

11.9

125

589

SPAT1167

SPAT

Insertion of urinary catheter

1.9

11.9

181

984

P99

ICPC

Psychological disorders other

2.0

11.9

145

724

C71.93

ICD-10 Finland

Malignant tumor in an unspecified localization in the brain grade IV glioma

46.7

11.9

C71

ICD-10 Finland

Malignant neoplasm of brain

46.7

11.9

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.3

11.8

1185

9624

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.8

11.8

194

1081

85100

ICD-8 Finland

Cerebral laceration and contusion, Without mention of open intracranial wound

7.0

11.8

9680/3-C71.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of brain, NOS

14.6

11.8

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

2.9

11.7

250

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.8

11.7

208

1188

9070A

ICD-9 Finland

Late effects of injuries to the nervous system, Late effect of intracranial injury without mention of skull fracture

10.5

11.7

C79.39

ICD-10 Finland

Secondary malignant tumor of the meninges, ventricle or other part of the brain

10.5

11.7

F06.2

ICD-10 Finland

Organic delusional [schizophrenia-like] disorder

8.9

11.7

4373A

ICD-9 Finland

Other and ill-defined cerebrovascular disease, Cerebral aneurysm, nonruptured

9.6

11.7

F40.2

ICD-10 Finland

Specific (isolated) phobias

3.5

11.7

152

W06

ICD-10 Finland

Fall involving bed

3.6

11.7

147

JN4AD

NOMESCO Finland

Body CT examination

1.5

11.7

380

2552

N06AA09

ATC

amitriptyline; systemic

1.4

11.7

489

3463

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.8

11.7

211

1214

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

2.6

11.6

316

D33.0

ICD-10 Finland

Benign neoplasm: Brain, supratentorial

30.0

11.6

C71.89

ICD-10 Finland

Overall malignant tumor of the brain other or unspecified histology

30.0

11.6

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.6

11.6

325

2110

PAF14

NOMESCO Finland

Thrombendarterectomy of internal carotid artery

2.5

11.6

342

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.7

11.6

216

1256

ZX120

NOMESCO Finland

Intravenous

1.4

11.6

499

3557

XF404

NOMESCO Finland

Ambulatory ECG

1.4

11.5

487

3455

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.2

11.5

117

544

3456B

ICD-9 Finland

Epilepsy, Infantile spasms[EPILEPSIA MYOCLONICA CUM ASTASIA]

+∞

11.5

G80.0

ICD-10 Finland

Spastic quadriplegic cerebral palsy

13.6

11.4

C71.91

ICD-10 Finland

Malignant tumor in unspecified location in the brain grade II glioma

120.2

11.4

4301A

ICD-9 Finland

Subarachnoid haemorrhage[HAEMORRHAGIA SUBARACH.POST MALFORMAT.ARTERIOVENOSAM]

120.2

11.4

N06AG02

ATC

moclobemide; oral

1.7

11.4

223

1314

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.5

11.4

371

2493

F06.7

ICD-10 Finland

Mild cognitive disorder

2.0

11.4

135

668

F06.0

ICD-10 Finland

Organic hallucinosis

7.4

11.4

WX725

NOMESCO Finland

Noninvasive ventilation

1.7

11.4

238

1428

Z02.7

ICD-10 Finland

Issue of medical certificate

1.6

11.3

319

2074

RS230

NOMESCO Finland

3.9

11.3

116

I63

ICD-10 Finland

Cerebral infarction

3.6

11.3

136

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.1

11.3

122

580

S01.1

ICD-10 Finland

Open wound of eyelid and periocular area

2.0

11.3

143

728

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

0.7

11.2

322

4649

85190

ICD-8 Finland

Cerebral laceration and contusion, Late effect

9.6

11.2

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

1.5

11.2

408

2812

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

3.8

11.2

122

TPX22

NOMESCO Finland

Intravenous arterial thrombolysis

3.2

11.2

174

K59.09

ICD-10 Finland

Constipation, unspecified

1.6

11.2

317

2066

I50.9

ICD-10 Finland

Heart failure, unspecified

1.4

11.1

687

5209

C71.9

ICD-10 Finland

Malignant neoplasm: Brain, unspecified

25.0

11.1

205

Kela drug reimbursment

Chronic hypertension

1.2

11.1

1493

12546

D33.2

ICD-10 Finland

Benign neoplasm: Brain, unspecified

20.0

11.1

A98

ICPC

Health maint/preventive medicine

0.8

11.1

6273

64841

R51

ICD-10 Finland

Headache

1.6

11.1

265

1651

S00.1

ICD-10 Finland

Contusion of eyelid and periocular area

2.2

11.1

114

533

N06AB03

ATC

fluoxetine; oral

1.4

11.0

636

4769

I60.3

ICD-10 Finland

Subarachnoid haemorrhage from posterior communicating artery

8.5

11.0

RT150

NOMESCO Finland

4.4

11.0

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

1.9

11.0

169

922

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.5

11.0

367

2481

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.2

10.9

1986

17218

PA2KT

NOMESCO Finland

Endovascular closure of brain aneurysm

6.6

10.9

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

4.3

10.9

H55

ICD-10 Finland

Nystagmus and other irregular eye movements

4.3

10.9

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

1.9

10.9

161

867

J01DA01

ATC

[U] cefalexin; systemic

1.2

10.9

3814

35064

S00.0

ICD-10 Finland

Superficial injury of scalp

2.1

10.9

117

555

ZXM20

NOMESCO Finland

Intraoperative use of computerised tomography

3.6

10.9

130

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

2.4

10.9

359

G93.4

ICD-10 Finland

Encephalopathy, unspecified

6.2

10.9

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

2.7

10.8

275

AAF99

NOMESCO Finland

Other shunt operation on ventricle of brain or intracerebral cyst

6.9

10.8

G93.6

ICD-10 Finland

Cerebral oedema

15.5

10.8

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

3.0

10.7

211

WC105

NOMESCO Finland

Simple cytostatic therapy of local tumor recidive

5.0

10.7

P72

ICPC

Schizophrenia

2.2

10.7

104

474

F07.0

ICD-10 Finland

Organic personality disorder

28.0

10.7

S01.9

ICD-10 Finland

Open wound of head, part unspecified

2.2

10.7

106

487

F20.9

ICD-10 Finland

Schizophrenia, unspecified

2.1

10.7

116

556

96698

ICD-8 Finland

Other antiepileptics

60.1

10.6

G05.1

ICD-10 Finland

Encephalitis, myelitis and encephalomyelitis in viral diseases classified elsewhere

60.1

10.6

C71.81

ICD-10 Finland

Overall malignant tumor of the brain grade II glioma

60.1

10.6

A10AA02

ATC

1.8

10.6

183

1039

N03AA03

ATC

primidone; oral

7.0

10.5

N87

ICPC

Parkinsonism

2.6

10.5

299

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

2.3

10.5

393

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

1.9

10.5

157

850

34520

ICD-8 Finland

Epilepsy, Status epilepticus

+∞

10.4

9505/1-C71.9

ICD-O-3

Ganglioglioma, NOS, of brain, NOS

+∞

10.4

9382/3-C71.9

ICD-O-3

Oligoastrocytoma, NOS, of brain, NOS

+∞

10.4

G40.5

ICD-10 Finland

Special epileptic syndromes

+∞

10.4

R2110

NOMESCO Finland

Giving the first information

1.5

10.4

343

2313

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.1

10.4

109

515

OAB95

SPAT

0.5

10.3

1588

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

2.1

10.3

118

579

K92.0

ICD-10 Finland

Haematemesis

2.0

10.3

133

684

G83.8

ICD-10 Finland

Other specified paralytic syndromes

10.6

10.2

I69.4

ICD-10 Finland

Sequelae of stroke, not specified as haemorrhage or infarction

8.8

10.2

5AB01

NOMESCO Finland

8.8

10.2

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.0

10.2

129

658

WX402

NOMESCO Finland

General anaesthesia

1.3

10.2

863

6849

F60.9

ICD-10 Finland

Personality disorder, unspecified

2.5

10.2

310

F54

ICD-10 Finland

Psychological and behavioural factors associated with disorders or diseases classified elsewhere

4.0

10.2

P15

ICPC

Chronic alcohol abuse

1.9

10.1

145

775

A02BC01

ATC

omeprazole; systemic

1.2

10.1

1480

12540

J01FF01

ATC

clindamycin; systemic

1.2

10.1

1440

12164

P01

ICPC

Feeling anxious/nervous/tense

1.4

10.1

522

3846

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.3

10.1

965

7782

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.7

10.1

198

1168

CS494

NOMESCO Finland

Other visual field testing

2.1

10.1

116

570

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.4

10.1

505

3700

WX002

NOMESCO Finland

Sedation and analgesia

1.3

10.0

1024

8327

M05BA04

ATC

alendronic acid; oral

1.5

10.0

389

2714

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.3

10.0

664

5091

XF600

NOMESCO Finland

Bloodpressure measurement

1.5

10.0

347

2367

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

3.4

10.0

140

F34.1

ICD-10 Finland

Dysthymia

1.8

10.0

165

926

9539/1-C70.0

ICD-O-3

Atypical meningioma of cerebral meninges

14.6

10.0

N04AA02

ATC

biperiden; systemic

2.1

10.0

104

491

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

1.8

10.0

170

961

G80.8

ICD-10 Finland

Other cerebral palsy

40.1

10.0

AAK85

NOMESCO Finland

Replantation of previously excised part of skull cap

40.1

10.0

SPAT1276

SPAT

Outlining of treatment with patient or their family members

2.0

10.0

126

641

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

1.9

9.9

149

808

SPAT1255

SPAT

Intravenous administration of medicine

1.5

9.9

324

2183

J96.0

ICD-10 Finland

Acute respiratory failure

2.5

9.9

296

J01CF02

ATC

cloxacillin; systemic

2.0

9.9

121

608

F43.21

ICD-10 Finland

Adaptation disorder with prolonged depression

2.9

9.9

208

J45.9

ICD-10 Finland

Asthma, unspecified

1.3

9.8

908

7289

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

1.4

9.8

396

2786

9663A

ICD-9 Finland

Poisoning by anticonvulsants and anti-Parkinsonism drugs, Other and unspecified anticonvulsants[MYRKYTYS:KARBAMATSEPIINI]

26.0

9.8

I69

ICD-10 Finland

Sequelae of cerebrovascular disease

4.7

9.8

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.5

9.8

313

2098

G83.9

ICD-10 Finland

Paralytic syndrome, unspecified

7.0

9.8

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.8

9.7

170

971

A99

ICPC

Disease/condition unspecnature/site

1.4

9.7

395

2785

S80.0

ICD-10 Finland

Contusion of knee

1.5

9.7

315

2117

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.6

9.7

246

1561

ZZA00

NOMESCO Finland

Split skin graft

1.9

9.7

145

788

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.2

9.7

2344

20821

N06AB05

ATC

paroxetine; oral

1.5

9.6

295

1956

D33.04

ICD-10 Finland

Temporal lobe

55.0

9.6

C71.02

ICD-10 Finland

Malignant tumor of the cerebrum except lobes and ventricles grade III glioma

55.0

9.6

RS313

NOMESCO Finland

5.3

9.6

F61.0

ICD-10 Finland

Mixed personality disorders

2.3

9.6

391

S82.6

ICD-10 Finland

Fracture of lateral malleolus

1.5

9.6

298

1985

S09.9

ICD-10 Finland

Unspecified injury of head

2.6

9.6

253

C07AB02

ATC

metoprolol; systemic

1.3

9.6

1080

8880

Z29

ICPC

Social problem NOS

2.1

9.6

110

540

AAL10

NOMESCO Finland

Intracranial endovascular thrombolysis

3.5

9.6

124

S02.10

ICD-10 Finland

Fracture of base of skull, closed

4.3

9.5

F10.06

ICD-10 Finland

Alcohol-related acute intoxication with seizures

8.4

9.5

XX1ZW

NOMESCO Finland

Very extensive written report from radiologist

4.5

9.5

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.4

9.5

443

3207

R1100

NOMESCO Finland

General evaluation of the need for rehabilitation

2.4

9.5

337

E86

ICD-10 Finland

Volume depletion

2.0

9.5

120

612

P03

ICPC

Feeling depressed

1.4

9.4

456

3321

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.5

9.4

316

2143

F70

ICD-10 Finland

Mild mental retardation

17.5

9.4

WZA90

NOMESCO Finland

Other doctors statement

1.2

9.4

1267

10635

4311A

ICD-9 Finland

Intracerebral haemorrhage[HAEMORRHAGIA INTRACEREBRALIS HYPERTONIA NON INDICAT]

12.3

9.3

SPAT1262

SPAT

Handing over of treatment supplies

1.3

9.3

944

7663

S06.8

ICD-10 Finland

Other intracranial injuries

6.9

9.3

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

2.7

9.3

229

G35

ICD-10 Finland

Multiple sclerosis

2.2

9.3

386

ZX090

NOMESCO Finland

Other technic of radiotherapy

1.9

9.3

139

754

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

1.8

9.3

151

845

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

2.4

9.2

301

P76

ICPC

Depressive disorder

1.5

9.2

294

1972

M01AE03

ATC

ketoprofen; systemic, rectal

1.2

9.2

2041

17975

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

2.3

9.2

361

SPAT1172

SPAT

Guidance concerning hydration

2.0

9.1

118

608

78259

ICD-8 Finland

Symptoms referable to cardiovascular and lymphatic system, Syncope (lipothymia) alia sive NUD

6.7

9.1

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

1.7

9.1

190

1145

F06.4

ICD-10 Finland

Organic anxiety disorder

9.0

S20.2

ICD-10 Finland

Contusion of thorax

1.6

9.0

245

1586

L16

ICPC

Ankle symptom/complaint

1.4

8.9

512

3836

F99

ICD-10 Finland

Mental disorder, not otherwise specified

2.1

8.9

101

495

6489X

ICD-9 Finland

Other current conditions in the mother classifiable elsewhere but complicating pregnancy, childbirth and the puerperium, Other current conditions classifiable elsewhere

6.5

8.9

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.4

8.9

451

3312

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

3.5

8.9

116

80090

ICD-8 Finland

Fracture of vault of skull, Late effect

24.0

8.9

SPAT1285

SPAT

Provision of consultation response

1.5

8.9

276

1841

ZX070

NOMESCO Finland

Intensity modified radiotherapy

2.1

8.9

100

486

A12BA01

ATC

potassium chloride; oral

1.6

8.9

228

1454

K08.3

ICD-10 Finland

Retained dental root

1.5

8.9

340

2370

H47.1

ICD-10 Finland

Papilloedema, unspecified

3.9

8.9

R20.2

ICD-10 Finland

Paraesthesia of skin

1.5

8.8

311

2132

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.3

8.8

923

7523

OAA80

SPAT

0.5

8.8

1543

S42.0

ICD-10 Finland

Fracture of clavicle

1.8

8.8

147

831

N02AX02

ATC

tramadol; systemic, rectal

1.2

8.8

2335

20865

AA9CW

NOMESCO Finland

5.1

8.7

I61.6

ICD-10 Finland

Intracerebral haemorrhage, multiple localized

5.9

8.7

AAM10

NOMESCO Finland

Excision of intracerebral abscess

50.0

8.7

WW806

NOMESCO Finland

Transfer from treating institution to lower-Level care, accompanied by doctor

50.0

8.7

I95.9

ICD-10 Finland

Hypotension, unspecified

2.3

8.7

340

N05AL01

ATC

sulpiride; systemic

2.3

8.6

353

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

1.7

8.6

167

985

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

2.8

8.6

186

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

1.7

8.6

165

974

N06AX21

ATC

duloxetine; oral

1.3

8.6

518

3918

R07.4

ICD-10 Finland

Chest pain, unspecified

1.2

8.5

1390

11880

AAD00

NOMESCO Finland

Evacuation of epidural haematoma

16.3

8.5

I68.0

ICD-10 Finland

Cerebral amyloid angiopathy

16.3

8.5

C70.0

ICD-10 Finland

Malignant neoplasm: Cerebral meninges

16.3

8.5

M05BX04

ATC

denosumab; parenteral

1.6

8.5

219

1396

F00.20*G30.8

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

2.2

8.5

394

3199A

ICD-9 Finland

Unspecified mental retardation[MUU ÄLYLLINEN KEHITYSVAMMAISUUS,EI KÄYTTÄYTYMIHÄIRI]

27.5

8.5

PA7RT

NOMESCO Finland

Medical infusion to cerebral artery

20.0

8.5

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

2.0

8.5

102

514

F05.0

ICD-10 Finland

Delirium not superimposed on dementia, so described

5.1

8.4

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.2

8.4

3013

27533

RL140

NOMESCO Finland

4.7

8.4

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.6

8.4

216

1379

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.5

8.4

319

2223

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.4

8.3

354

2518

N03AF03

ATC

rufinamide; oral

+∞

8.3

AA5FM

NOMESCO Finland

Functional MRI examination of brain with 3 Tesla magnet

+∞

8.3

C71.03

ICD-10 Finland

Malignant tumor of cerebellum except lobes and ventricles grade IV glioma

+∞

8.3

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

2.2

8.3

392

7802X

ICD-9 Finland

General symptoms, Syncope and collapse[SYNCOPE ET COLLAPSUS NUD]

3.3

8.3

123

A02BA02

ATC

ranitidine; systemic

1.2

8.3

996

8246

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

2.0

8.3

463

AAA20

NOMESCO Finland

Insertion of intraventricular pressure monitoring device

5.5

8.3

G91.8

ICD-10 Finland

Other hydrocephalus

9.4

8.3

JDB10

NOMESCO Finland

Percutaneous gastrostomy

2.3

8.2

310

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

2.5

8.2

253

UKC02

NOMESCO Finland

Cystoscopy

1.3

8.2

820

6646

N05AC02

ATC

thioridazine; oral

2.0

8.2

104

533

C10AA05

ATC

atorvastatin; oral

1.2

8.2

1960

17339

280

Kela drug reimbursment

Clopidogrel

2.2

8.2

377

WF099

NOMESCO Finland

Other radiotherapy

3.4

8.1

109

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

2.2

8.1

368

P70

ICPC

Dementia

2.0

8.1

486

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

4622

28873

2.36

309.90

7.3

6.3

mmol/l

1.2

30.51

4357

26182

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

684

124.15

307.65

3.3

2.1

umol/l

30.0

27.7

0.53

529

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

427

366

12.24

307.65

1.8

1.7

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

4161

18914

3.41

307.65

3.4

2.1

u/l

228.8

218.6

0.18

4030

17710

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

1181

335.77

307.65

2.6

2.0

umol/l

55.2

44.5

1.45

1045

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

235

92.97

307.65

3.4

3.0

umol/l

42.5

39.2

0.22

217

(3009466) Valproate [Moles/volume] in Serum or Plasma

1285

616

24.51

307.65

3.7

5.6

umol/l

369.3

363.8

0.37

1127

520

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2278

10025

2.76

307.65

2.3

28.9

30.0

12.15

2211

9725

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

846

2119

4.33

305.40

2.4

ug/l

353.7

587.7

1.33

806

1992

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

211

25.14

300.45

2.3

2.0

umol/l

20.6

14.7

4.26

211

(3027801) Oxygen [Partial pressure] in Arterial blood

1762

7221

2.83

291.22

7.4

7.2

kpa

14.2

12.4

25.63

1689

6866

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1762

7223

2.83

291.05

7.4

7.2

kpa

5.0

5.1

1.94

1689

6866

(3003396) Base excess in Arterial blood by calculation

1756

7200

2.83

289.82

7.4

7.2

mmol/l

1.1

1.0

0.86

1353

5550

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

699

1581

4.74

286.77

1.5

1.6

mg/l

542.4

505.7

0.88

670

1501

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

408

549

7.76

286.58

1.8

1.4

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

4858

31930

2.26

275.85

8.2

6.9

mmol/l

1.2

25.40

4249

26992

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

637

1393

4.87

271.95

1.4

1.6

mmol/l

3.8

3.7

1.54

598

1303

(3044290) Cell count panel - Cerebral spinal fluid

591

1284

4.88

253.98

1.6

1.7

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

609

1391

4.65

246.07

1.6

1.7

e6/l

21.3

19.6

0.10

487

1066

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

608

1391

4.64

245.15

1.7

e6/l

1936.8

3556.4

0.26

510

1123

(3013826) Glucose [Moles/volume] in Serum or Plasma

5332

38304

2.10

216.74

7.1

4.7

mmol/l

6.6

6.7

2.77

5122

35649

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

115

68.57

210.97

1.0

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

306

470

6.72

190.02

1.5

1.2

mmol/l

2.2

2.0

1.73

284

436

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1341

5940

2.50

182.07

8.4

8.0

g/l

123.7

121.7

3.07

1303

5719

(3016502) Oxygen saturation in Arterial blood

1423

6479

2.44

181.97

8.3

7.6

96.2

95.6

2.20

1376

6227

(3023183) Ammonium ion [Moles/volume] in Plasma

519

1332

4.09

179.21

2.9

umol/l

32.1

34.6

1.30

443

1140

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

239

320

7.66

168.07

1.2

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

236

313

7.73

167.33

1.2

1.1

—

(3023368) Bacteria identified in Blood by Culture

2843

17603

1.94

161.78

4.5

4.3

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

226

303

7.64

158.72

1.7

1.4

—

(3032080) INR in Blood by Coagulation assay

3770

25834

1.84

154.27

9.2

9.3

inr

1.2

1.3

3.80

1068

7467

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

3545

24050

1.83

147.96

4.8

3.6

ng/l

49.7

80.1

0.58

2695

16115

(3016018) Differential panel - Cerebral spinal fluid

330

692

4.92

147.00

1.5

1.7

—

(3018418) pH of Serum or Plasma

2908

18654

1.86

144.66

4.1

7.4

0.84

529

3553

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1016

4405

2.49

142.21

6.1

8.3

mmol/l

24.3

24.8

4.40

1008

4375

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

839

3341

2.68

139.92

6.8

9.6

mmol/l

24.2

0.00

809

3096

(3008152) Bicarbonate [Moles/volume] in Arterial blood

939

3952

2.55

139.88

10.2

6.6

mmol/l

24.6

24.5

0.54

892

3670

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1852

10409

2.00

135.85

4.0

3.7

mmol/l

0.8

0.16

1730

9708

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

927

3986

2.49

131.58

7.7

9.1

1.4

1.34

921

3958

(3019060) Gas panel - Arterial blood

951

4143

2.46

131.20

7.3

4.6

—

(3014007) Fractional oxyhemoglobin in Arterial blood

917

4006

2.45

125.48

7.9

9.2

94.2

94.0

0.30

917

3990

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1811

10480

1.93

120.10

2.0

1.8

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

1488

8064

2.03

119.17

6.7

7.1

mmol/l

103.3

104.6

14.65

1454

7892

(3003181) Sodium [Moles/volume] in Urine

381

1046

3.77

119.05

1.5

mmol/l

72.5

64.8

2.28

318

846

(3018405) Lactate [Moles/volume] in Arterial blood

605

2212

2.87

118.24

5.0

3.9

mmol/l

1.5

1.4

2.09

599

2173

(3014111) Lactate [Moles/volume] in Serum or Plasma

1156

5731

2.18

117.06

5.8

7.3

mmol/l

1.4

1.3

1.60

1090

5487

(3043409) Potassium [Moles/volume] in Arterial blood

541

1871

3.02

116.87

5.3

4.0

mmol/l

3.9

0.87

518

1758

(3020191) Ethanol [Moles/volume] in Serum or Plasma

249

506

5.04

114.94

1.8

1.4

promille

0.7

1.4

9.20

199

393

(3024561) Albumin [Mass/volume] in Serum or Plasma

3813

27753

1.69

114.58

5.5

5.0

g/l

35.0

35.6

7.60

3577

25757

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1174

5979

2.12

110.50

2.3

2.2

nmol/l

373.3

370.5

0.18

1081

5497

(3020891) Body temperature

641

2555

2.63

105.72

6.1

4.7

—

(3023410) Appearance of Cerebral spinal fluid

276

654

4.33

105.48

1.7

2.2

—

(3000991) Gas panel - Venous blood

1127

5780

2.10

103.69

6.5

8.7

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

143

187

7.76

102.53

1.3

1.1

—

(3033658) Prothrombin time (PT) actual/Normal

2494

16653

1.71

99.81

4.5

4.2

89.8

89.0

0.96

2430

16233

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1311

7206

1.97

99.20

1.9

1.8

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1304

7184

1.97

97.91

1.8

1.7

—

(3026008) Bacteria identified in Urine by Culture

2745

18940

1.67

96.38

3.5

3.1

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

4267

33277

1.58

88.00

8.1

6.1

umol/l

9.9

11.9

22.28

4042

31495

(3015377) Calcium [Moles/volume] in Serum or Plasma

2954

21219

1.61

85.85

4.3

3.3

mmol/l

2.3

2.4

11.68

2619

18532

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

789

3795

2.19

84.75

1.6

1.5

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1162

6458

1.93

84.01

3.7

4.5

kpa

5.9

5.8

1.86

1129

6262

(3002032) Base excess in Venous blood by calculation

1152

6437

1.92

81.79

3.7

4.5

mmol/l

2.0

1.8

0.89

969

5176

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1329

7780

1.84

81.57

10.3

7.0

—

(3024354) Oxygen [Partial pressure] in Venous blood

1005

5372

1.99

81.26

3.5

4.1

kpa

4.6

4.7

0.37

974

5192

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

123

184

6.77

78.18

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

119

175

6.88

76.86

1.2

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

119

179

6.73

75.25

1.2

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

114

167

6.91

73.89

1.1

—

(3012544) pH of Venous blood

1156

6670

1.85

73.72

3.7

4.5

7.4

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

119

183

6.58

73.69

1.1

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

100.98

72.97

1.1

1.0

—

(3031040) Bacteria [#/volume] in Urine by Automated count

5156

43009

1.53

71.12

5.5

4.4

e6/l

2875.0

1705.8

0.52

604

(3019309) Folate [Moles/volume] in Red Blood Cells

1797

11888

1.65

70.22

1.9

1.8

nmol/l

1203.5

1165.0

1.08

1431

8974

(3036489) Thrombin time

553

2503

2.30

68.42

2.1

2.7

21.4

21.7

0.41

505

2186

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

987

5553

1.88

67.78

2.7

2.3

ug/l

5.9

7.3

2.03

853

4821

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

12.59

66.56

1.2

1.0

—

(3044640) Blood type and Crossmatch panel - Blood

2794

20715

1.53

66.14

2.6

2.5

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

147

307

4.86

65.71

1.7

1.2

47.2

68.7

2.07

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1385

8715

1.71

64.89

5.4

6.5

mmol/l

1.0

1.1

3.03

1282

8127

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

128

245

5.29

63.26

1.2

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

212

619

3.49

60.27

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

9.30

60.04

1.2

1.1

—

(3026782) Osmolality of Urine

1879

12984

1.58

59.99

2.9

2.8

mosm/kgh2o

547.8

553.2

0.48

1626

11081

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1684

11352

1.61

59.68

3.2

3.0

mmol/l

2.4

2.5

6.36

1473

9902

(3013650) Neutrophils [#/volume] in Blood by Automated count

4594

38124

1.46

59.61

11.2

9.1

e9/l

4.0

4.1

1.59

4051

33203

(3020779) Urea [Moles/volume] in Serum or Plasma

1028

6082

1.79

59.49

6.4

8.0

mmol/l

7.8

9.8

17.59

976

5801

(3006315) Basophils [#/volume] in Blood

4094

33260

1.46

59.26

6.8

6.1

e9/l

0.0

11.03

3560

28675

(3001604) Monocytes [#/volume] in Blood

4075

33122

1.45

58.54

6.8

6.0

e9/l

0.6

0.08

3546

28532

(3008295) Osmolality of Serum or Plasma

214

645

3.38

57.90

1.4

1.5

mosm/kgh2o

279.5

280.6

0.25

157

505

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

590

2926

2.09

57.87

3.0

3.2

0.7

1.79

572

2796

(3019198) Lymphocytes [#/volume] in Blood

4174

34148

1.45

57.51

6.9

6.1

e9/l

1.8

1.9

2.33

3684

30009

(3013115) Eosinophils [#/volume] in Blood

4191

34353

1.45

56.90

7.2

6.3

e9/l

0.2

18.45

3691

30099

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

8.91

55.71

1.2

1.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

186

530

3.57

54.90

1.2

1.1

mg/l

38.2

40.6

0.36

158

435

(40761535) Cells panel - Urine sediment

898

5244

1.80

54.00

3.9

3.5

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

5691

49650

1.47

53.81

9.5

7.4

u/l

81.0

79.6

1.12

5401

46735

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

568

2865

2.05

53.13

4.3

51.4

48.7

1.91

561

2826

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

180

514

3.56

52.96

1.2

1.1

mg/l

262.7

260.0

0.06

164

448

(3004119) Hemoglobin [Mass/volume] in Venous blood

712

3894

1.91

52.74

3.6

3.7

g/l

129.7

129.3

0.19

700

3797

(1761868) Lipid panel - Serum or Plasma

1655

23040

0.65

52.12

2.8

2.7

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

596

3080

2.01

52.11

3.7

mmol/l

25.2

0.06

581

2981

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

9.31

51.80

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

124

275

4.56

51.59

4.9

12.4

—

(3019150) Specific gravity of Urine by Refractometry

1958

14085

1.51

50.72

5.1

3.9

kg/l

1.0

0.17

270

2149

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

171

486

3.57

50.68

1.1

—

(3022217) INR in Platelet poor plasma by Coagulation assay

1288

8433

1.62

50.55

26.4

25.4

inr

1.4

0.18

138

1239

(4035726)

910

5446

1.75

50.12

1.4

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

644

3467

1.93

49.95

11.1

9.8

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2145

15822

1.48

48.80

2.5

2.4

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

114

253

4.55

47.41

1.1

ng/l

96.9

434.5

1.61

(42870588) Differential panel, method unspecified - Blood

2889

22672

1.42

46.76

6.7

6.2

—

(4027681)

145

410

3.58

43.35

1.3

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

138

5.77

43.15

1.1

1.4

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

744

4389

1.76

42.78

4.2

4.3

mmol/l

1.6

1.7

0.09

554

3207

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

499

2603

1.98

42.31

8.9

4.9

1.7

1.6

0.41

465

2428

(3016038) Potassium [Moles/volume] in Urine

145

417

3.52

42.26

1.5

1.4

mmol/l

32.8

35.7

0.76

128

365

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

200

702

2.89

41.83

1.5

1.7

—

(3009343) pH of Capillary blood

759

4533

1.74

41.76

4.2

4.3

7.4

0.66

507

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

766

4591

1.74

41.61

4.3

kpa

5.2

5.1

1.72

711

4249

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

144

5.53

41.26

1.1

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

493

2588

1.96

41.02

9.0

5.0

0.9

1.59

459

2419

(40758558) Short blood count panel - Blood

2201

16763

1.43

40.90

8.1

7.1

—

(3010421) pH of Blood

366

1728

2.17

40.59

4.3

4.4

7.4

3.90

307

1459

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

651

3788

1.78

39.13

1.7

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2569

20232

1.39

38.92

3.1

2.6

u/l

58.4

57.9

0.08

2395

18714

(3039000) Anion gap in Blood

311

1404

2.26

38.51

12.3

6.7

mmol/l

11.0

11.3

0.89

280

1251

(3018572) Chloride [Moles/volume] in Blood

311

1405

2.26

38.44

12.3

6.7

mmol/l

104.7

105.1

0.44

280

1252

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3672

30655

1.36

38.41

4.5

4.1

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2681

21302

1.38

38.36

4.1

3.3

u/l

32.4

34.7

0.67

2532

20200

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

18.81

37.84

1.1

1.0

—

(3029937) Albumin [Presence] in Urine by Test strip

2217

17186

1.40

36.39

5.0

4.0

estimate

0.0

2.37

659

5804

(3028271) Lactate [Moles/volume] in Capillary blood

247

1037

2.42

36.14

2.3

1.9

mmol/l

2.3

1.7

7.37

241

1017

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

130

5.42

35.86

1.1

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

7167

67000

1.52

35.42

25.9

16.0

mmol/l

138.4

139.7

181.62

7056

65247

(3011397) Hemoglobin [Presence] in Urine by Test strip

1981

15124

1.41

35.38

4.4

3.6

—

(3012501) Base excess in Blood by calculation

314

1487

2.15

34.56

4.4

4.5

mmol/l

2.3

2.5

0.62

220

993

(3013290) Carbon dioxide [Partial pressure] in Blood

314

1488

2.15

34.50

4.4

4.5

kpa

5.1

5.0

1.66

307

1458

(3027315) Oxygen [Partial pressure] in Blood

315

1495

2.15

34.47

4.4

4.5

kpa

8.7

8.6

0.24

308

1464

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

11.29

34.42

1.0

1.1

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

609

3618

1.74

33.93

3.4

5.0

mmol/l

24.1

24.0

0.59

559

3287

(3022096) Basophils/100 leukocytes in Blood

3589

30217

1.33

33.92

7.1

6.3

0.6

0.7

4.34

3386

28208

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

6.54

33.54

1.6

1.1

48.9

59.3

0.62

(3030467) Casts [#/volume] in Urine by Automated count

2324

18351

1.37

33.53

3.4

3.2

e6/l

0.4

0.00

1865

13817

(3000850) Epithelial cells [#/volume] in Urine

1834

13944

1.40

33.22

2.8

2.7

e6/l

5.9

5.4

0.68

1655

12205

(3006504) Eosinophils/100 leukocytes in Blood

3676

31138

1.32

32.96

7.1

6.3

2.6

2.9

11.46

3459

29026

(4198724)

117

345

3.42

32.89

1.6

3.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

135

436

3.13

32.75

1.2

1.1

—

(3019069) Monocytes/100 leukocytes in Blood

3693

31324

1.32

32.70

7.4

6.5

9.0

8.6

8.91

3482

29340

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1661

12494

1.41

31.81

4.4

3.7

ng/l

245.8

536.7

2.55

1297

9631

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

199

4.20

31.38

1.4

1.2

22.1

28.5

0.28

(3002582) Erythrocytes [#/volume] in Urine

2491

20045

1.35

31.35

3.5

3.3

e6/l

65.7

95.0

1.02

2012

15414

(36304419) Bacteria [Presence] in Urine

2255

17895

1.36

31.03

3.4

3.2

—

(3018095) Leukocytes [#/volume] in Urine

2839

23346

1.33

30.65

4.1

3.8

e6/l

99.4

93.7

0.08

2153

16543

(3047181) Lactate [Moles/volume] in Blood

379

2009

1.93

30.58

11.3

5.7

mmol/l

1.4

1.3

0.91

333

1762

(3023103) Potassium [Moles/volume] in Serum or Plasma

7146

67204

1.46

29.79

25.2

16.2

mmol/l

4.0

0.21

7019

65313

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

383

2055

1.91

29.79

2.6

3.3

g/l

3.4

3.5

0.36

364

1955

(3021960) Folate [Moles/volume] in Serum or Plasma

1882

14605

1.37

29.60

1.6

1.5

nmol/l

18.0

20.2

9.06

1679

12555

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

11.11

29.30

1.2

1.4

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

408

2247

1.86

29.27

3.4

3.8

u/ml

0.4

0.3

1.14

277

1277

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

164

629

2.64

29.07

1.6

1.8

—

(1616796) Gas panel - Central venous blood

302

1514

2.03

28.60

3.7

3.8

—

(3002030) Lymphocytes/100 leukocytes in Blood

3754

32281

1.30

28.60

7.2

6.3

26.9

28.2

9.82

3541

30079

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

449

2573

1.79

28.28

2.5

1.9

ug/l

3.2

2.5

0.42

375

2262

(40767503) Oxygen content in Capillary blood by calculation

283

1395

2.06

28.07

2.7

2.5

17.0

16.4

1.66

134

726

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1144

8226

1.45

27.70

2.1

1.7

1.4

16.66

1018

7247

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

6.03

27.57

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

117

385

3.07

27.56

1.0

ng/l

288.0

322.0

0.70

264

(3018010) Neutrophils/100 leukocytes in Blood

3693

31789

1.29

27.51

6.9

6.1

57.7

56.9

3.18

3494

29745

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

4894

43712

1.29

27.18

4.3

3.1

u/l

65.3

46.9

23.98

4639

40818

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

116

387

3.03

26.69

1.0

ng/l

743.9

741.8

0.01

258

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

116

389

3.01

26.46

1.0

ng/l

37.5

44.6

1.28

264

(3037467) Urinalysis macro (dipstick) panel - Urine

5032

45181

1.29

26.45

5.0

4.2

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

108

351

3.10

26.01

1.1

u/l

1.0

1.1

0.24

165

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

429

2489

1.76

25.89

2.0

1.8

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

711

4712

1.56

25.47

1.8

1.7

—

(3035350) Ketones [Presence] in Urine by Test strip

3689

31954

1.28

25.39

4.5

3.6

estimate

0.0

1.34

670

5919

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

348

1907

1.86

25.37

1.3

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

340

5954

0.55

25.22

1.7

—

(3019225) pH of Specimen

882

6162

1.48

24.59

4.6

4.3

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

5903

63213

0.77

24.12

4.3

4.2

mmol/l

1.5

1.4

4.21

5462

58479

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2085

16856

1.32

24.09

2.2

2.3

mg/l

3.0

2.9

0.40

1759

14459

(3022806) Fractional oxyhemoglobin in Capillary blood

188

839

2.27

24.03

2.2

1.8

89.3

89.6

0.30

183

831

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1027

7450

1.43

23.45

4.3

u/l

250.3

242.6

0.51

965

7035

(3028707) Methadone [Presence] in Urine by Screen method

252

1277

2.00

23.21

2.2

3.1

—

(3007853) Bacteria identified in Skin by Aerobe culture

1076

7889

1.42

23.13

1.9

1.8

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

6087

64813

0.77

22.81

4.8

4.7

mmol/l

2.7

7.47

5633

59892

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

5.13

22.80

1.1

1.0

—

(3028626) Oxygen [Partial pressure] in Capillary blood

354

2023

1.78

22.51

4.5

4.7

kpa

8.8

8.6

1.03

338

1888

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3032

25927

1.27

22.20

2.1

2.0

pmol/l

93.9

95.1

0.74

1678

13735

(3009261) Glucose [Presence] in Urine by Test strip

3690

32346

1.25

21.65

4.5

3.6

estimate

0.0

2.20

663

5871

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1782

14288

1.31

21.45

1.9

mg/l

1.2

0.08

1374

10831

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

184

855

2.18

21.36

5.8

6.9

mg/l

10.4

11.6

3.46

160

783

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

5980

63689

0.78

21.33

4.3

4.2

mmol/l

4.6

1.55

5564

59233

(21494755) Public health laboratory ask at order entry panel

408

6526

0.61

21.30

1.3

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

4.91

21.27

1.1

1.0

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

6997

66315

1.36

21.21

21.8

14.0

mg/l

24.1

24.0

0.04

6055

52303

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1441

11225

1.34

21.18

2.9

2.8

e6/l

1.2

1.1

0.54

862

6434

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2892

24723

1.26

20.85

4.8

3.7

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

305

1706

1.82

20.85

3.1

3.5

mmol/l

24.1

24.7

1.71

280

1481

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

477

3020

1.61

20.71

4.9

4.7

mmol/l

24.8

24.7

0.62

445

2801

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

340

1972

1.75

20.56

2.5

3.1

187.0

187.4

0.03

324

1878

(3021601) Nitrite [Presence] in Urine by Test strip

3642

31999

1.25

20.53

5.8

4.8

estimate

0.0

0.80

682

6046

(3024869) Neuronal Ab [Presence] in Serum

101

4.67

20.49

1.1

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

7.96

19.99

1.9

1.1

27.0

35.0

0.34

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

215

4001

0.52

19.48

1.4

—

(4034850)

345

2042

1.72

19.42

12.0

9.7

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

6.06

18.54

1.2

1.1

11.8

21.0

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1680

13608

1.29

18.35

1.7

pmol/l

37217973.4

30136084.6

0.19

1416

11352

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

274

2.97

18.33

1.9

2.4

umol/l

162.0

157.2

0.04

152

(3014271) Vancomycin [Susceptibility]

319

2.81

18.14

3.0

2.9

—

(3022313) Gas panel - Capillary blood

511

3397

1.54

17.95

4.6

—

(3052851) Hemolysis interference index of Serum or Plasma

328

1960

1.70

17.85

3.6

3.3

—

(3042936) Bacteria identified in Isolate by Culture

1184

9208

1.33

17.28

2.2

2.0

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

6.02

17.28

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

5.33

17.26

1.1

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

423

2736

1.58

16.79

2.1

1.9

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

352

2185

1.64

16.58

2.4

3.2

95.5

91.3

2.56

331

2052

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

5749

61027

0.81

16.41

3.9

3.8

mmol/l

1.3

0.13

5309

56096

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1321

10535

1.30

16.00

3.2

3.0

e6/l

3.6

2.4

3.29

750

5785

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

5375

49869

1.22

15.95

4.3

3.9

pmol/l

14.3

14.8

33.36

4949

45395

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

133

616

2.18

15.68

2.7

2.9

—

(3006653) Thiamine [Moles/volume] in Blood

299

2.73

15.67

1.1

1.3

nmol/l

138.2

136.6

0.08

299

(3020630) Protein [Mass/volume] in Serum or Plasma

715

5210

1.41

15.66

2.3

2.5

g/l

66.2

66.4

0.19

643

4734

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

248

1425

1.76

15.57

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

248

1425

1.76

15.57

1.4

1.3

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2122

17972

1.24

15.55

3.2

3.1

ng/l

1507.2

1546.0

0.13

1856

15366

(3021589) Normoblasts [#/volume] in Blood

3315

29418

1.21

15.34

11.1

9.7

e9/l

0.0

0.24

2706

23944

(3005719) IgG [Mass/volume] in Serum or Plasma

694

5063

1.40

15.09

2.5

2.7

g/l

10.3

10.5

0.40

629

4637

(3027945) Reticulocytes/100 erythrocytes in Blood

977

7547

1.33

14.80

3.0

2.7

1.8

1.7

2.02

863

6687

(3035637) Corticotropin [Mass/volume] in Plasma

172

897

1.94

14.73

1.5

1.6

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

251

2.80

14.34

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

309

2.60

14.20

2.5

2.4

—

(3040151) Glucose [Moles/volume] in Capillary blood

151

763

2.00

14.18

10.6

6.6

mmol/l

7.4

7.3

0.12

132

635

(3023520) Reticulocytes [#/volume] in Blood

748

5595

1.37

13.97

2.7

e9/l

71.0

68.8

0.89

558

4193

(3028679) Herpes simplex virus Ab [Presence] in Serum

343

2.49

13.80

1.2

—

(3021901) Oxygen saturation in Capillary blood

214

1226

1.76

13.62

2.7

3.0

—

(3017569) Oxygen content in Arterial blood

300

2.55

12.95

1.6

2.3

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

553

4018

1.40

12.30

1.3

au/ml

32.2

53.0

1.94

169

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

794

6120

1.33

12.13

2.5

2.4

g/l

0.2

0.46

738

5690

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

3.99

11.88

1.8

2.0

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

593

4392

1.38

11.76

2.3

2.4

au/ml

42.8

22.2

2.18

256

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

205

1214

1.71

11.66

1.6

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

171

964

1.79

11.56

1.2

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

311

2.42

11.56

1.7

2.1

—

(3004588) Protein electrophoresis panel - Serum or Plasma

572

4239

1.37

11.30

2.1

2.3

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

173

986

1.77

11.29

1.3

u/ml

3.3

4.3

1.01

435

(3045716) Anion gap in Serum or Plasma

293

2.43

11.08

2.2

mmol/l

10.4

9.3

0.83

223

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

136

3.17

11.05

1.2

1.1

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

290

1905

1.54

10.85

1.7

—

(44790049)

140

769

1.83

10.36

1.5

1.6

—

(44790047)

140

769

1.83

10.36

1.5

1.6

—

(44790048)

140

769

1.83

10.36

1.5

1.6

—

(44806118)

140

769

1.83

10.36

1.5

1.6

—

(3024928) Oxygen saturation in Venous blood

221

1385

1.61

10.15

2.7

3.8

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1049

12677

0.80

9.81

2.7

3.0

ug/l

0.8

0.11

733

8364

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

671

5205

1.31

9.78

4.3

4.0

mmol/l

1.2

5.23

625

4547

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

3.53

9.74

1.0

2.3

—

(40757494) Bilirubin.total [Moles/volume] in Blood

356

2.20

9.71

2.2

2.5

umol/l

42.2

42.9

0.01

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

4.11

9.41

1.0

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2930

26499

1.16

9.38

2.3

nmol/l

73.6

76.4

6.11

2611

23951

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1413

16497

0.83

9.35

1.6

mmol/l

1.4

0.52

1231

13972

(3011985) Renin [Units/volume] in Plasma

147

849

1.74

9.24

1.6

1.5

mu/l

60.1

69.4

0.25

134

747

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

307

2120

1.46

9.09

2.6

—

(40757373) Influenza virus identified in Isolate

137

2.93

9.04

1.6

1.5

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

128

718

1.79

8.91

3.5

4.3

—

(3001019) Free T4 and TSH panel - Serum or Plasma

217

3290

0.65

8.90

1.7

—

(3009542) Hematocrit [Volume Fraction] of Blood

5886

61389

0.86

8.88

22.9

14.9

38.8

39.9

16.37

3954

45116

(1001926) Buprenorphine [Presence] in Urine by Screen method

329

2315

1.44

8.83

2.1

2.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

182

1128

1.63

8.81

1.4

1.5

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

407

2975

1.39

8.79

1.7

g/l

1.4

1.5

1.01

326

2561

(40761511) CBC panel - Blood by Automated count

7092

68770

1.22

8.68

20.2

13.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

104

3.18

8.60

1.0

1.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

230

1517

1.53

8.53

2.2

g/l

133.5

129.8

1.58

189

1092

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

3.80

8.49

1.0

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

226

1491

1.53

8.38

1.6

1.7

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

165

1011

1.64

8.38

1.3

1.2

u/ml

4.1

4.0

0.03

326

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

238

1591

1.51

8.30

1.7

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

812

6594

1.26

8.24

4.2

3.4

—

(3028433) Virus identified in Specimen by Culture

239

2.35

8.22

1.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

303

2.19

8.17

1.1

—

(3011412) CD3 cells [#/volume] in Blood

122

696

1.76

8.06

2.5

2.7

e9/l

1.0

1.2

1.54

427

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

7.07

7.99

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

300

2.18

7.95

1.2

1.1

miu/ml

1685.9

1513.0

0.53

300

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

232

1558

1.50

7.94

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

536

1.86

7.78

1.6

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

536

1.86

7.78

1.6

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

536

1.86

7.78

1.6

1.7

—

(3052592) Norovirus Ag [Presence] in Stool

127

2.84

7.77

1.9

1.3

—

(3051651) Icteric interference index of Serum or Plasma

412

1.98

7.68

2.4

3.9

—

(3016879) Cocaine [Presence] in Urine

373

2770

1.36

7.36

2.1

2.3

—

(3017509) Phencyclidine [Presence] in Urine

3.60

7.28

1.5

1.7

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

228

2.29

7.23

1.5

pmol/l

13.4

15.1

1.08

193

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

145

898

1.63

7.13

1.4

u/l

22.6

25.3

0.52

120

749

(3013512) EKG study

2017

18049

1.16

7.02

4.4

3.9

—

(3044889) 12 lead EKG panel

4714

44611

1.13

6.90

4.0

3.7

—

(3000764) Benzodiazepines [Presence] in Urine

391

2965

1.33

6.75

2.0

2.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

131

803

1.64

6.73

1.2

1.4

pmol/l

297.9

292.4

0.06

109

601

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

562

6996

0.79

6.73

1.4

1.5

—

(3011288) Drugs identified in Urine by Screen method

276

1982

1.41

6.70

2.9

3.4

—

(3028300) Cannabinoids [Presence] in Urine

393

2987

1.33

6.68

2.1

2.2

—

(3023419) Bacteria identified in Sputum by Culture

126

767

1.65

6.66

2.5

2.7

—

(3027008) Opiates [Presence] in Urine

392

2982

1.33

6.63

2.0

2.1

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1656

14664

1.16

6.59

5.5

4.6

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

278

2007

1.40

6.56

2.2

1.6

g/l

1.2

0.04

267

1899

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

270

1943

1.40

6.49

2.2

1.7

g/l

0.2

0.95

260

1838

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

123

2.69

6.48

1.3

1.8

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

510

1.79

6.48

2.5

2.8

e6/l

473.1

501.6

0.24

419

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

222

3136

0.70

6.39

1.4

1.5

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

114

685

1.67

6.35

2.6

3.0

nmol/l

21.0

20.4

0.25

102

661

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

492

1.80

6.32

2.5

2.9

e9/l

0.2

0.34

415

(3004809) Band form neutrophils/100 leukocytes in Blood

165

1085

1.53

6.32

3.1

3.7

1.6

1.5

0.11

136

827

(3000093) Morphology [Interpretation] in Blood Narrative

105

619

1.70

6.28

1.1

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

173

1156

1.51

6.16

1.8

—

(4268621)

112

677

1.66

6.12

2.5

2.3

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

438

3424

1.29

6.10

3.0

2.8

e6/l

0.4

0.3

0.61

428

3342

(3022948) Iron [Moles/volume] in Serum or Plasma

1205

10469

1.18

6.08

2.4

2.6

umol/l

12.9

13.1

0.30

1098

9710

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

383

1.89

6.07

2.8

2.6

43.4

38.1

1.17

132

(3027944) Amphetamines [Presence] in Urine

381

2928

1.32

6.03

2.1

2.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

251

1811

1.40

5.98

1.2

—

(3037756) Immunofixation for Serum or Plasma

188

1290

1.47

5.90

1.3

1.6

—

(3013707) Erythrocyte sedimentation rate by Westergren method

5046

48165

1.12

5.89

4.1

4.0

mm/h

12.3

11.8

1.29

4722

44613

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

205

1431

1.44

5.88

1.3

1.4

—

(3017181) Myelocytes/100 leukocytes in Blood

668

5517

1.23

5.83

4.5

4.3

1.1

0.9

1.34

229

1564

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

244

2.10

5.80

3.0

2.4

nmol/l

140.6

147.6

0.23

206

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

144

939

1.54

5.77

1.6

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

559

1.71

5.76

2.3

2.5

15.1

12.9

0.62

291

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

6184

59788

1.13

5.73

5.2

4.6

mu/l

2.0

2.1

0.10

5764

54883

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

488

3900

1.27

5.72

2.8

3.2

pmol/l

4.3

4.5

5.04

438

3459

(1175426) CD3 cells/100 lymphocytes in Blood

572

1.69

5.57

2.4

2.5

74.4

71.7

0.99

546

(3039443) Prostate specific Ag panel - Serum or Plasma

1250

0.56

5.56

1.5

1.6

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

543

1.70

5.53

2.5

2.4

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

629

5193

1.23

5.52

3.4

2.6

ml/min/173m2

72.0

66.7

2.11

264

2069

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

131

847

1.56

5.48

1.4

—

(3051611) Lipemic interference index of Serum or Plasma

108

668

1.62

5.44

2.8

3.6

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

122

778

1.58

5.42

3.5

2.4

—

(3035285) Chloride [Moles/volume] in Venous blood

124

797

1.56

5.33

3.5

2.4

mmol/l

104.6

105.6

1.35

124

787

(3041354) Potassium [Moles/volume] in Venous blood

124

799

1.56

5.28

3.5

2.4

mmol/l

4.1

0.26

124

789

(3037121) Protein [Mass/volume] in Urine

306

2329

1.33

5.23

3.3

3.6

g/l

0.2

0.3

2.35

160

1075

(3019977) pH of Arterial blood

354

1.84

5.16

2.3

2.8

7.4

0.48

125

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

146

982

1.50

5.11

1.4

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

10.01

5.02

1.2

1.0

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

194

1385

1.41

4.98

5.5

6.2

iu/ml

361.1

1685.7

0.64

201

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

316

1.87

4.95

1.6

1.9

162.7

143.1

1.11

301

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

142

957

1.49

4.94

1.2

1.1

118.6

114.7

0.79

125

860

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

329

2553

1.30

4.91

2.6

2.3

u/l

6066.4

5495.5

0.12

102

1009

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.82

4.80

1.7

4.5

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

370

1.79

4.80

1.2

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1102

9684

1.16

4.78

2.4

2.5

g/l

2.3

1.20

1019

8964

(3049233) Organic acids panel - Urine

4.59

4.77

1.5

1.2

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

715

6075

1.19

4.69

2.6

2.5

u/l

38.2

44.8

0.37

611

5206

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

452

1.69

4.52

1.1

1.2

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

877

10066

0.86

4.51

1.3

1.2

u/ml

19.5

11.5

0.55

349

3915

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

579

4843

1.21

4.50

3.7

4.2

ng/l

80.3

90.4

2.33

493

4193

(3014148) Varicella zoster virus Ab [Titer] in Serum

131

887

1.48

4.49

1.2

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.86

4.48

2.3

2.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

174

2399

0.72

4.45

1.6

1.7

mg/l

4.8

3.8

0.40

128

1663

(3002179) Metamyelocytes/100 leukocytes in Blood

598

5026

1.20

4.43

4.3

4.1

0.7

0.6

0.27

150

1137

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

120

1764

0.68

4.41

1.4

1.5

—

(3050129) First trimester maternal screen panel - Serum or Plasma

143

2034

0.70

4.40

1.6

1.4

—

(3000492) Spirometry study

528

6317

0.82

4.40

1.5

1.4

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

189

2.07

4.38

2.7

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

189

2.07

4.38

2.7

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1025

9019

1.16

4.37

2.5

2.6

22.7

0.02

847

7723

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

5707

58829

0.90

4.36

5.6

mmol/mol

39.1

39.6

3.36

5308

54604

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

109

1625

0.67

4.31

1.3

1.4

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

352

2808

1.26

4.27

1.6

u/ml

29.3

14.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

109

1619

0.67

4.24

1.3

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

109

1619

0.67

4.24

1.3

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

110

1623

0.67

4.15

1.3

1.4

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

152

1077

1.42

4.14

3.1

3.8

u/ml

383.1

1844.0

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

214

1.97

4.14

1.0

1.1

77.9

88.0

0.62

109

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

142

2.19

4.03

1.0

1.2

63.6

77.3

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

142

2.19

4.03

1.0

1.2

74.7

70.7

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

10.00

4.01

1.0

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

107

714

1.50

3.99

1.2

1.1

92.0

95.5

0.78

669

(3008898) HLA-B27 [Presence]

169

2296

0.73

3.98

1.0

1.1

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

101

666

1.52

3.98

2.7

3.7

58.1

57.9

0.03

415

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

253

1.86

3.96

2.7

2.5

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

7127

69919

1.14

3.95

14.0

10.1

u/l

27.1

26.7

0.30

6966

67413

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

128

890

1.44

3.89

1.5

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

114

775

1.48

3.89

1.3

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

100

2.40

3.88

1.0

1.4

ng/l

46.3

68.5

0.35

(40768800) Prostate Pathology biopsy report

1345

0.66

3.82

1.1

1.2

—

(3021440) Promyelocytes/100 leukocytes in Blood

614

5250

1.18

3.79

4.7

4.3

0.2

0.1

0.25

209

1460

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.53

3.78

1.3

1.4

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

8.75

3.77

1.0

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

115

789

1.46

3.76

1.7

1.6

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

331

1.73

3.76

2.2

1.7

u/field

1.3

3.4

1.89

236

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

309

1.75

3.75

1.1

u/ml

30.3

19.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

303

2416

1.26

3.74

1.7

1.6

mu/l

348.9

298.6

1.51

278

2188

(3015171) Extractable nuclear Ab [Units/volume] in Serum

307

2453

1.26

3.72

1.2

u/ml

0.5

0.9

0.63

223

(3006245) CD3-CD19+ cells/100 cells in Blood

325

1.73

3.71

2.5

2.9

11.5

12.0

0.06

306

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

311

1.74

3.67

3.3

3.5

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

210

1.91

3.66

1.1

1.2

71.5

86.0

0.84

109

(3017315) Amylase [Enzymatic activity/volume] in Urine

342

1.70

3.64

1.1

1.2

u/l

350.1

330.6

0.06

314

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

3.67

3.63

2.2

5.5

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.53

3.62

2.2

2.0

—

(4306422)

140

1004

1.40

3.62

1.3

1.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

419

1.63

3.61

1.4

—

(40768804) Tissue Pathology biopsy report

2742

25790

1.09

3.59

2.2

2.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1321

0.67

3.52

1.4

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2059

22112

0.91

3.52

4.3

4.9

ug/l

3.2

3.3

0.10

1835

19877

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

3.85

3.51

1.0

1.1

mg/l

0.1

0.0

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

249

1.81

3.51

1.7

1.9

186.4

168.8

0.58

236

(3009214) Lutropin [Units/volume] in Serum or Plasma

269

2133

1.27

3.50

1.5

u/l

10.6

9.0

1.06

219

1677

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

614

7092

0.85

3.45

1.7

—

(3000494) Fungus identified in Specimen by Culture

855

7556

1.15

3.45

1.5

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

456

1.58

3.44

1.5

u/l

13.0

12.9

0.02

437

(3002256) Pathology report gross observation

726

8276

0.87

3.42

1.2

1.3

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

411

1.61

3.39

1.4

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

850

7524

1.14

3.35

3.3

3.0

umol/l

6.4

8.2

4.26

718

6520

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1354

0.68

3.35

1.4

1.5

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

122

869

1.41

3.31

1.3

nmol/l

0.2

0.3

—

(3005033) Fetal Nuchal fold Thickness US

1314

0.68

3.29

1.4

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

240

1893

1.28

3.28

1.4

1.5

—

(3028026) IgM [Mass/volume] in Serum or Plasma

466

3946

1.19

3.26

1.8

1.9

g/l

1.2

1.3

1.01

423

3606

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1629

17635

0.90

3.25

4.0

4.2

21.6

22.0

0.45

782

8480

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

122

2.13

3.24

1.2

1.3

mg/l

0.9

146.0

1.44

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

4.74

3.23

1.1

1.4

nmol/l

700.7

446.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

198

1.87

3.23

1.6

1.7

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

1080

0.65

3.21

1.2

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

178

1.91

3.17

1.1

1.3

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

277

2236

1.25

3.13

1.7

1.6

titre

473.8

312.4

0.26

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

689

1.44

3.08

1.1

1.2

—

(4094501)

125

1702

0.73

3.08

1.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

167

1270

1.32

3.04

1.3

1.4

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

137

1013

1.36

3.01

1.2

1.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

965

10703

0.89

3.00

1.2

1.3

iu/ml

31.9

31.5

0.03

260

3264

(3006922) Hepatitis E virus Ab [Presence] in Serum

457

1.54

2.98

1.1

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

378

1.59

2.98

11.1

11.9

mmol/l

0.6

0.13

348

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

3.00

2.96

1.2

1.1

u/l

1.6

5.8

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

241

1929

1.26

2.96

2.7

3.4

mg/l

31.0

54.4

2.32

209

1564

(4010399)

518

4466

1.17

2.95

1.5

1.4

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

241

1932

1.25

2.92

2.8

3.4

mg/l

49.2

88.9

0.71

209

1564

(3025159) Blasts/100 leukocytes in Blood

571

4965

1.16

2.92

4.8

4.3

0.3

0.02

174

1226

(3022145) Colonoscopy Study observation

621

7070

0.87

2.90

1.3

1.4

—

(42529406) Shigella sp [Presence] in Stool by Culture

237

1900

1.25

2.88

1.3

1.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

109

1498

0.72

2.87

1.5

1.6

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

138

1030

1.35

2.87

1.2

1.4

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

6.67

2.86

1.0

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

233

1870

1.25

2.81

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

235

1889

1.25

2.80

1.2

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

274

2242

1.23

2.78

2.3

2.2

g/l

3.1

0.31

187

1748

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

627

5512

1.15

2.77

3.0

3.1

ng/l

183.5

212.4

1.26

567

4993

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

8.34

2.75

1.2

1.3

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

8.34

2.75

1.2

1.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

247

1.70

2.74

3.0

2.8

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

234

1887

1.25

2.72

2.8

3.3

ratio

20.4

2.2

0.46

145

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

510

1.47

2.67

2.5

2.7

e6/l

676.5

655.8

0.08

186

(3024891) Influenza virus A+B Ag [Presence] in Specimen

227

1830

1.25

2.66

1.2

1.1

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

291

2410

1.21

2.64

2.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

291

2412

1.21

2.62

2.2

g/l

7.1

7.4

1.78

191

1778

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

679

1.40

2.61

1.3

—

31.6

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

6091

62147

0.92

2.60

4.5

4.4

mmol/l

5.9

1.64

5581

56785

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

417

1.51

2.57

1.6

1.5

—

(3026250) Tacrolimus [Mass/volume] in Blood

322

1.59

2.56

30.9

37.5

ug/l

7.1

7.3

0.38

298

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

171

1.82

2.53

1.3

ug/l

17.3

335.5

1.22

(3020874) Milk IgE Ab [Units/volume] in Serum

474

0.55

2.51

1.1

1.2

u/ml

1.0

2.9

—

187

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

157

1.85

2.51

1.1

1.2

pmol/l

322.2

266.6

0.43

111

(3042517) Benzodiazepines panel - Urine

2.27

2.50

4.0

2.7

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

289

2408

1.21

2.49

2.2

g/l

3.7

3.8

0.38

185

1705

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

195

1.75

2.45

2.6

3.1

—

(3004451) EKG impression Narrative

310

1.58

2.45

1.3

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

166

1.81

2.43

1.5

1.4

nmol/l

118.8

130.1

0.14

123

(3014599) Egg white IgE Ab [Units/volume] in Serum

469

0.55

2.43

1.2

u/ml

2.4

8.6

—

162

(3028308) Erythrocytes [#/volume] in Pleural fluid

689

1.38

2.42

1.4

1.5

e6/l

90866.9

61730.6

0.39

407

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

681

1.38

2.41

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

139

1069

1.31

2.41

1.1

1.2

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

138

1.89

2.40

2.8

2.3

mmol/l

1.4

1.6

0.09

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

128

974

1.32

2.40

1.2

1.3

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

316

2671

1.19

2.35

1.8

1.9

u/l

39.1

0.01

286

2363

(21494815) CD4 cells/100 lymphocytes in Specimen

620

1.39

2.29

2.1

2.6

43.6

41.5

—

(3023511) Choriogonadotropin [Units/volume] in Urine

160

1263

1.27

2.29

1.5

1.3

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

163

1.78

2.26

1.4

—

(3000060) B lymphocytes [#/volume] in Blood

254

1.62

2.26

2.4

2.8

e6/l

1091.5

257.2

0.41

146

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

3.89

2.25

1.1

3.7

—

(3023199) Leukocytes [#/volume] in Pleural fluid

103

768

1.35

2.24

1.4

1.5

e6/l

2223.6

2258.0

0.03

558

(3028717) Thiamine [Mass/volume] in Blood

2.27

2.24

1.1

1.3

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

142

1.83

2.22

3.0

2.7

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

516

1.42

2.19

2.3

2.0

u/field

2.2

1.7

0.35

203

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

244

2029

1.21

2.19

2.2

2.3

g/l

0.8

0.9

0.16

199

1742

(3019897) Erythrocyte distribution width [Ratio] by Automated count

841

0.69

2.17

4.0

2.6

13.5

13.1

1.28

829

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.07

2.16

1.2

1.1

—

(3011648) Oxygen content in Venous blood

552

1.40

2.14

2.3

4.0

11.1

0.01

552

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.30

2.14

1.6

1.3

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

370

1.49

2.13

1.1

nmol/l

0.1

11.2

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1177

12689

0.92

2.13

1.6

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

212

1.65

2.12

2.3

2.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1171

0.74

2.10

1.4

1.5

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

339

1.51

2.10

1.4

1.5

ug/l

6.1

8.0

1.25

298

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

138

1083

1.28

2.10

1.2

1.1

iu/ml

8404.8

8643.9

0.01

273

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

300

1.54

2.07

1.3

1.6

nmol/l

1.6

5.9

1.78

237

(3034426) Prothrombin time (PT)

229

1.62

2.07

1.2

—

(21494814) CD8 cells/100 lymphocytes in Specimen

261

1.57

2.05

2.2

—

(1002224) Polysomnography panel

223

2672

0.83

2.04

1.1

—

(3019174) dRVVT (LA screen)

2.32

2.04

1.1

1.2

—

(40760888) Immunoglobulin light chains.free panel - Serum

181

1472

1.23

2.04

3.0

3.5

—

(3007566) Smooth muscle Ab [Titer] in Serum

218

1810

1.21

2.01

1.3

titre

147.8

158.1

0.05

151

(3042111) Morphology [Interpretation] in Bone marrow Narrative

137

1081

1.27

2.01

1.8

1.7

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

3.08

2.01

1.0

1.3

nmol/l

219.4

305.9

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

216

1793

1.21

2.00

1.4

1.5

iu/ml

15.4

13.9

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

102

776

1.32

1.97

1.9

2.1

mg/l

51.2

24.2

2.04

194

(3034770) Mitochondria Ab [Titer] in Serum

216

1798

1.21

1.95

1.2

1.3

titre

720.0

1046.5

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

216

1799

1.21

1.94

2.1

2.2

g/l

0.0

0.04

187

1642

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

264

2245

1.18

1.89

2.3

g/l

10.4

10.2

0.32

203

1894

(3026692) Albumin [Mass/volume] in Peritoneal fluid

158

1.71

1.88

1.3

1.5

g/l

12.0

13.4

0.28

123

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

231

1945

1.19

1.86

2.1

1.8

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

964

0.73

1.86

1.1

u/ml

2.5

3.3

0.43

441

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.92

1.79

1.2

1.1

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.34

1.77

1.3

1.0

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

258

0.50

1.74

1.0

1.2

u/ml

11.1

17.6

—

164

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2999

28907

1.06

1.73

3.0

2.9

ug/l

140.8

125.6

1.61

2763

26824

(3003694) ABO and Rh group [Type] in Blood

1967

18720

1.07

1.73

1.4

1.5

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1838

19325

0.94

1.72

3.9

4.0

mg/mmol

12.0

10.0

0.75

1207

12482

(3042951) Complement C1q Ab [Units/volume] in Serum

2.67

1.72

1.0

1.1

—

23.6

—

(3000963) Hemoglobin [Mass/volume] in Blood

7329

73964

0.92

1.71

31.8

20.5

g/l

132.9

135.8

52.26

7247

72894

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

155

1.68

1.71

1.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

125

1.76

1.71

1.1

1.2

umol/24h

0.7

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

432

1.39

1.69

1.1

—

(3026361) Erythrocytes [#/volume] in Blood

7328

73946

0.92

1.68

31.6

20.4

e12/l

4.4

4.5

80.49

7180

71788

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

283

1.49

1.68

1.2

—

(3035941) MCH [Entitic mass]

7327

73933

0.92

1.67

31.4

20.3

30.5

30.2

26.10

7245

72866

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

481

4315

1.12

1.66

1.2

iu/ml

89.5

147.0

3.53

184

1571

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

434

1.38

1.65

1.1

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

2.10

1.65

3.7

3.4

mg/l

0.8

1.5

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

198

1666

1.19

1.65

2.1

2.2

g/l

0.0

0.45

169

1516

(3024731) MCV [Entitic volume]

7328

73936

0.92

1.64

31.5

20.3

91.0

90.7

8.18

7247

72868

(3010813) Leukocytes [#/volume] in Blood

7331

73965

0.92

1.64

31.6

20.4

e9/l

6.8

0.07

7188

71789

(3045788) Cell count panel - Pleural fluid

598

1.32

1.64

1.4

1.5

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

156

1284

1.22

1.63

1.8

1.7

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

2.14

1.60

1.0

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

311

1.45

1.60

1.4

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

311

1.45

1.60

1.4

1.5

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.50

1.59

1.1

1.4

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

2.06

1.59

6.4

9.4

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.69

1.58

1.0

1.5

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

101

1273

0.79

1.57

1.1

u/ml

2.1

2.4

0.07

344

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

202

2374

0.85

1.56

1.5

1.7

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

1024

0.77

1.55

1.1

u/ml

2.1

4.2

1.65

441

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.11

1.54

2.3

2.6

—

(3044009) aPTT.lupus sensitive (LA screen)

2.11

1.54

1.1

1.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

217

1853

1.18

1.54

2.1

g/l

37.7

37.6

0.06

177

1588

(3018738) Hemoglobin F/Hemoglobin.total in Blood

2.03

1.53

3.9

3.5

8.8

4.3

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

2.42

1.53

1.0

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

469

0.66

1.53

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.97

1.53

3.4

2.4

u/field

0.4

0.6

0.69

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

3.33

1.52

1.0

1.3

—

(3016135) IgD [Mass/volume] in Serum

3.33

1.52

1.0

1.1

mg/l

21.4

70.1

—

(4024509)

606

1.31

1.51

1.8

1.5

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

225

1.51

1.50

1.1

1.2

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

2.86

1.50

1.2

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

123

1.71

1.50

1.1

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

123

1.71

1.50

1.1

1.2

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1560

14807

1.07

1.49

1.3

u/ml

1.6

2.0

0.71

439

3879

(3007461) Platelets [#/volume] in Blood

7327

73887

0.92

1.49

31.6

20.4

e9/l

247.9

250.3

2.33

7201

71926

(3025468) Yersinia sp identified in Specimen by Organism specific culture

103

820

1.26

1.49

1.4

1.5

—

(3012441) Differential panel - Pleural fluid

670

1.29

1.48

1.4

1.5

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

210

1.53

1.47

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

139

1.66

1.47

1.4

1.9

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

125

1525

0.82

1.47

1.2

1.1

u/ml

1.4

2.1

0.54

695

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

163

1.60

1.45

1.2

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

725

1.27

1.45

1.3

1.2

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

195

1.54

1.45

1.6

1.9

e6/l

13508.9

16018.5

0.07

113

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

105

842

1.25

1.44

1.4

1.5

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

3.13

1.43

1.0

2.4

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1624

17040

0.94

1.42

2.9

2.7

umol/l

2812.7

4503.7

1.20

1393

14821

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

103

826

1.25

1.41

1.4

1.5

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

554

0.70

1.41

1.3

pmol/l

173.8

118.8

0.17

169

(40768806) Pleura Pathology biopsy report

675

1.28

1.41

1.4

1.6

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

262

1.45

1.40

1.1

1.3

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

238

1.47

1.38

1.2

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

238

1.47

1.38

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

238

1.47

1.38

1.2

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

134

1.64

1.38

1.5

1.3

—

(3022621) pH of Urine by Test strip

467

4234

1.11

1.38

3.7

2.9

—

(3029075) Extractable nuclear Ab panel - Serum

198

0.50

1.37

1.0

1.1

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

192

1642

1.17

1.37

2.2

g/l

0.0

0.00

169

1512

(3017937) Magnesium [Moles/time] in 24 hour Urine

2.94

1.36

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

111

1357

0.82

1.35

1.9

1.8

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

102

822

1.24

1.35

1.4

1.5

—

(3026389) Candida sp identified in Specimen by Organism specific culture

113

921

1.23

1.35

1.4

1.3

—

(1617658) Protocol used for examination of sentinel lymph nodes

407

0.66

1.34

1.0

1.1

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

197

1692

1.17

1.34

1.9

2.0

mg/l

11.8

11.4

0.20

179

1574

(3007164) IgA [Mass/volume] in Serum or Plasma

1385

13144

1.06

1.34

1.5

g/l

2.3

2.4

0.30

831

7963

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

142

1692

0.84

1.33

1.5

1.4

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

115

941

1.22

1.33

1.4

1.5

nmol/l

0.3

0.4

0.34

746

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

4299

43926

0.96

1.32

3.2

3.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

102

825

1.24

1.32

1.4

1.5

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

2.50

1.30

1.0

1.6

nmol/l

45.2

13.7

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

294

0.61

1.29

1.9

1.5

3.4

4.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

102

828

1.23

1.28

1.4

1.5

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.88

1.28

1.1

1.3

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.29

1.26

1.0

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

219

1.46

1.25

2.0

2.2

e6/l

651.8

4101.4

0.52

161

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

768

1.24

1.25

1.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

2.22

1.24

2.6

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

769

1.24

2.5

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

123

1.63

1.23

1.1

1.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

582

1.27

1.23

1.3

1.4

—

(3013336) Amino acids [Identifier] in Serum or Plasma

2.00

1.23

1.1

3.0

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

842

0.78

1.21

1.1

1.4

ug/l

2.7

4.4

2.27

758

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

246

1.42

1.20

1.1

1.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

407

0.69

1.19

1.0

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.83

1.19

1.2

1.1

—

(3003338) MCHC [Mass/volume]

5803

57197

1.05

1.19

28.0

17.7

g/l

334.4

332.8

30.76

5753

56707

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

216

1891

1.15

1.18

1.4

1.3

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

861

0.79

1.17

1.6

1.5

—

(3030313) Adrenal Ab [Titer] in Serum

1.88

1.17

1.6

1.2

—

(3017704) Immunofixation for Urine

341

1.35

1.17

1.6

1.5

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

552

1.27

1.15

1.2

1.3

titre

237.5

194.2

0.17

108

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

552

1.27

1.15

1.2

1.3

—

147.5

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

382

4202

0.90

1.15

1.2

—

(3035880) pH of Pleural fluid

352

1.34

1.13

1.2

1.3

—

(40768793) Breast Pathology biopsy report

102

1228

0.83

1.12

1.2

1.3

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

192

1.46

1.11

1.4

1.3

59.1

54.8

0.22

159

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

217

1.43

1.10

1.1

1.2

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

853

0.80

1.10

1.1

u/ml

0.0

0.5

2.58

241

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

251

1.40

1.10

1.2

1.1

—

(3010375) cycloSPORINE [Mass/volume] in Blood

354

1.33

1.09

22.8

26.1

ug/l

110.1

117.1

0.33

294

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

874

9267

0.94

1.09

1.4

1.5

—

(3017732) Neutrophils [#/volume] in Blood

490

4514

1.09

3.5

2.8

e9/l

4.0

4.2

0.50

369

3533

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

157

1352

1.16

1.09

1.5

1.6

—

(3001186) Copper [Moles/volume] in Serum or Plasma

160

1.50

1.08

1.1

1.4

umol/l

16.0

16.5

0.16

145

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

895

0.80

1.08

1.3

—

(3020491) Glucose [Moles/volume] in Blood

504

1.27

1.08

1.5

2.0

mmol/l

7.8

6.5

1.84

353

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

2.19

1.08

1.1

1.4

pmol/l

22.4

25.5

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

315

0.67

1.07

1.7

1.9

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.87

1.07

1.0

1.1

—

(3042631) Mycobacterium sp identified in Specimen

102

848

1.21

1.06

2.6

2.9

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

296

1.35

1.05

1.1

93.3

93.1

0.01

231

(3009677) Dengue virus Ab [Presence] in Serum

2.27

1.03

1.0

1.1

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

2.27

1.03

1.2

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

130

1.54

1.02

3.2

2.3

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

456

1.27

1.01

2.3

1.5

u/ml

30.3

22.4

0.69

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.69

1.01

1.4

1.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

1.89

1.01

1.4

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

908

0.81

1.01

1.3

mmol/l

6.5

7.2

1.53

661

(3022493) Free Hemoglobin [Mass/volume] in Plasma

290

1.35

1.00

6.7

5.4

mg/l

82.5

66.5

0.80

207

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

109

0.46

1.00

1.0

1.2

u/ml

0.0

4.8

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

466

1.27

0.99

1.8

1.7

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

176

0.57

0.99

1.6

1.9

—

139.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

161

1844

0.87

0.99

1.1

u/ml

4.6

6.4

0.26

233

(4146454)

663

0.78

0.99

2.4

2.7

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

127

1480

0.86

0.99

1.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

318

1.32

0.97

2.0

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

318

1.32

0.97

2.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

318

1.32

0.97

2.0

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

318

1.32

0.97

2.0

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.63

0.96

1.3

1.8

—

(3020961) Endomysium IgA Ab [Titer] in Serum

360

3298

1.10

0.94

1.2

1.1

titre

150.0

145.6

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.89

0.94

1.0

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

954

0.83

0.93

1.1

u/ml

7.0

5.6

0.18

415

(3003888) Timothy IgE Ab [Units/volume] in Serum

117

1363

0.86

0.92

1.1

u/ml

3.9

6.3

1.58

766

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

150

1.47

0.92

1.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

243

1.36

0.92

2.3

2.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

243

1.36

0.92

2.3

2.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

218

1.38

0.91

1.5

—

(3037522) Nuclear Ab [Titer] in Serum

922

8764

1.06

0.89

1.4

1.3

titre

550.7

529.6

0.14

194

1758

(3044941) Cell count panel - Synovial fluid

992

0.83

0.89

1.4

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

102

0.49

0.89

1.2

3.6

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

114

1325

0.86

0.88

1.1

u/ml

0.5

1.2

2.10

645

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

245

1.35

0.88

2.3

2.2

—

(3012516) Albumin [Mass/volume] in Urine

1779

18386

0.96

0.88

3.2

3.3

mg/l

651.4

392.4

1.14

1195

11867

(3013293) Extractable nuclear Ab [Presence] in Serum

1.61

0.87

1.5

1.6

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

738

0.81

0.87

1.1

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

195

1.39

0.85

1.1

1.2

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

841

7994

1.06

0.83

1.6

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

140

0.57

0.82

1.1

u/ml

11.3

55.5

—

134

(40765089) Chromosome analysis panel - Blood by G-banded

257

1.32

0.82

1.1

1.0

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

310

1.29

0.82

1.2

1.1

u/l

30.0

28.6

0.05

236

(3045424) Erythrocytes [Presence] in Urine

122

1060

1.15

0.81

1.5

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

1.64

0.81

1.2

1.1

u/ml

0.0

0.6

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

783

1.18

0.80

1.8

1.7

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

306

0.72

0.80

1.1

1.3

—

(1761482) Bacteria [#/volume] in Urine by Culture

184

1647

1.12

0.79

5.3

4.1

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

0.00

0.79

0.0

1.2

—

0.2

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

312

1.28

0.79

1.2

1.1

u/l

103.5

91.1

0.30

245

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

134

1177

1.14

0.78

3.3

3.5

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

574

1.20

0.78

1.4

1.3

e6/l

131170.9

106776.4

0.12

396

(44806071)

1.59

0.77

1.2

1.1

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.77

0.0

1.0

—

(3045142) Bone marrow Pathology biopsy report

722

1.18

0.77

1.4

—

(3033799) Differential panel - Peritoneal fluid

191

1.36

0.76

2.3

2.0

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

207

1870

1.11

0.76

1.3

1.4

ug/g

260.3

278.4

0.66

118

1077

(3036782) Glucose [Moles/volume] in Pleural fluid

603

1.20

0.76

1.3

1.4

mmol/l

5.9

6.3

0.89

558

(3048689) Calprotectin [Mass/mass] in Stool

786

8250

0.95

0.76

2.1

2.5

ug/g

141.2

132.9

0.22

620

6540

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.70

0.75

1.2

umol/24h

2.5

1.6

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

123

1078

1.14

0.75

1.6

g/l

0.8

0.02

826

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

940

0.85

0.75

2.4

2.9

u/ml

2710.6

429.7

0.40

891

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

504

0.79

0.75

1.6

mmol/l

7.0

7.7

0.67

307

(40758358) Immune stain study

2.08

0.74

1.0

—

(3019832) Treponema pallidum Ab [Presence] in Serum

634

6689

0.94

0.74

1.6

1.7

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

183

1647

1.11

0.73

1.9

1.8

—

(3009508) Creatinine [Moles/volume] in Urine

1977

20311

0.96

0.73

3.3

mmol/l

7.7

0.28

1679

17182

(3034274) Bile acid [Moles/volume] in Serum --fasting

894

0.85

0.72

2.1

2.6

umol/l

4.6

7.7

2.18

655

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

506

1.21

0.72

1.1

mg/l

283.2

284.2

0.03

450

(3011841) English Walnut IgE Ab [Units/volume] in Serum

107

0.56

0.72

1.0

1.1

u/ml

0.0

9.2

—

(4281824)

610

0.82

0.71

1.4

1.2

—

(3021788) Differential panel - Synovial fluid

1137

0.87

0.70

1.7

1.5

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

572

1.19

0.70

1.5

1.3

nmol/l

1.6

1.5

0.31

514

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

101

1.49

0.70

1.2

1.0

—

(21494890) Protein electrophoresis panel - 24 hour Urine

637

1.18

0.70

1.8

2.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.71

0.69

1.0

—

(3050794) Legionella sp Ab [Presence] in Serum

1.55

0.69

1.1

—

(3025941) Bacteria identified in Stool by Culture

402

3760

1.07

0.69

1.3

1.2

—

(40768795) Lymph node Pathology biopsy report

597

0.82

0.69

1.1

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

383

3578

1.07

0.68

1.7

1.9

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.67

0.68

1.0

—

(21494434) Karyotype in Bone marrow

565

1.19

0.68

1.3

1.2

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

136

1211

1.12

0.67

3.7

3.1

nmol/l

0.7

0.8

3.50

105

914

(3002385) Erythrocyte distribution width [Ratio]

5591

55335

1.03

0.67

25.4

16.9

13.6

0.31

5502

54132

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.79

0.66

1.0

1.1

—

(3005322) IgE [Units/volume] in Serum or Plasma

446

4196

1.07

0.66

1.3

u/ml

140.3

227.6

4.19

406

3889

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

745

0.84

0.66

1.9

1.6

56.8

59.0

0.18

473

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

297

2754

1.08

0.65

1.1

u/ml

1.2

1.4

—

(3015183) Erythrocyte sedimentation rate

327

0.76

0.64

1.1

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

174

1917

0.91

0.64

1.4

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

348

0.77

0.63

2.0

ug/min

133.3

178.4

—

(3020393) Adenovirus Ag [Presence] in Stool

129

1.40

0.63

1.6

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

654

1.16

0.62

1.2

u/l

69.0

73.0

0.11

434

(3041806) Other cells [#/volume] in Blood by Manual count

268

0.75

0.61

1.3

1.6

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

367

0.79

0.59

1.9

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

148

1.35

0.59

1.1

1.2

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.59

0.0

1.1

—

2.9

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

381

1.21

0.58

1.4

3.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

959

0.87

0.58

1.3

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

409

0.81

0.57

1.4

1.5

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

219

2022

1.09

0.56

4.8

6.1

mg/l

1.5

0.29

199

1880

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.67

0.56

1.0

1.7

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

474

4496

1.06

0.56

1.9

2.0

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

192

2087

0.92

0.56

1.5

1.6

iu/ml

22.9

4.6

0.44

450

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

319

0.78

0.56

5.6

4.2

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.62

0.55

1.0

1.7

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

393

1.20

0.55

1.2

ratio

1.1

0.94

130

(3014051) Protein [Presence] in Urine by Test strip

135

1490

0.90

0.54

2.1

2.2

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

579

1.16

0.54

4.5

4.9

u/ml

148.7

61.2

0.40

167

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

117

1301

0.90

0.54

3.1

3.5

u/ml

1260.1

646.1

0.27

106

1195

(3035320) C reactive protein [Mass/volume] in Body fluid

459

1.18

0.54

2.0

2.4

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

667

6396

1.05

0.53

3.9

4.1

ug/l

13.8

28.8

1.34

547

5179

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

135

0.67

0.51

2.9

2.5

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

126

1.35

0.51

1.1

1.2

mmol/l

1.8

1.6

—

(4212803)

1.38

0.50

1.1

1.0

—

(3023420) DNA double strand Ab [Units/volume] in Serum

668

1.14

0.50

2.3

1.4

iu/ml

30.2

24.8

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

444

1.17

0.50

1.1

1.2

—

(40765096) Chromosome analysis panel by Banding

202

0.74

0.50

1.2

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

115

1272

0.90

0.50

1.3

1.2

u/ml

58.9

38.2

0.60

124

(46235355) HIV 1 and 2 tests - Meaningful Use set

1315

12806

1.03

0.48

1.8

1.9

—

(3044927) Protein electrophoresis panel - Urine

624

1.14

0.48

1.5

1.2

—

(3014891) Appearance of Pleural fluid

1.40

0.48

1.8

1.6

—

(3000034) Microalbumin [Mass/volume] in Urine

603

0.86

0.47

3.4

3.1

mg/l

92.2

57.4

0.31

467

(3025018) Bordetella pertussis Ab [Titer] in Serum

430

0.84

0.47

1.3

1.2

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

191

1.26

0.46

1.1

1.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

1097

0.90

0.46

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

1097

0.90

0.46

1.1

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

683

1.13

0.46

1.3

1.4

g/l

0.4

0.01

487

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

203

2177

0.93

0.45

1.4

1.3

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.62

0.45

1.0

1.1

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

684

1.13

0.45

1.3

1.4

g/l

2.9

0.05

488

(3027135) IgG subclass 1 [Mass/volume] in Serum

684

1.13

0.45

1.3

1.4

g/l

6.8

6.7

0.05

484

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

440

1.16

0.45

1.1

1.2

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

156

1.28

0.45

1.9

nmol/l

0.1

0.2

1.67

113

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

220

0.77

0.44

1.8

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

139

1.30

0.43

1.0

1.3

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

130

0.69

0.43

2.1

1.7

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

500

0.86

0.42

1.1

1.2

—

(4062490)

688

1.12

0.42

1.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

793

8182

0.97

0.42

2.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

140

1.29

0.41

1.7

1.2

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

341

1.17

0.41

1.4

2.0

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

341

1.17

0.41

1.4

2.0

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

0.41

0.0

1.0

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.36

0.41

1.8

1.6

umol/l

57.6

42.9

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.36

0.41

1.0

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

277

1.19

0.40

1.0

1.1

u/ml

1.6

6.6

—

(3006462) Nitrate [Presence] in Urine

314

1.18

0.40

2.3

3.5

—

(3034614) HLA Ag [Interpretation]

0.00

0.40

0.0

1.3

—

(4211845)

342

1.17

0.40

2.3

3.4

—

(3007463) Buprenorphine [Presence] in Urine

1.47

0.40

3.4

5.9

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

0.40

0.0

8.4

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.31

0.39

1.0

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

390

1.15

0.39

1.5

1.6

u/l

4.3

6.1

0.54

189

(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum

0.00

0.39

0.0

1.1

—

17.0

—

(3014339) Estrone (E1) [Moles/volume] in Serum or Plasma

0.00

0.39

0.0

1.1

—

236.0

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

409

1.15

0.39

1.7

1.5

—

(40761536) Microorganisms panel - Urine sediment

582

5618

1.04

0.38

4.4

3.9

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.32

0.37

1.0

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

354

3385

1.05

0.36

1.3

1.4

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.66

0.35

1.6

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

441

1.13

0.35

1.2

1.1

—

(40768446) Kidney Pathology biopsy report

291

1.17

0.35

1.6

1.7

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

108

1.30

0.35

1.1

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

395

1.14

0.34

1.5

1.3

titre

113.3

367.0

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.37

0.34

1.3

1.5

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

881

1.09

0.34

1.1

g/l

1.5

0.56

784

(36660697) Celiac disease serology panel - Serum

560

5417

1.04

0.34

1.2

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

1.36

0.34

1.0

2.7

—

80.5

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

148

1383

1.07

0.34

4.0

3.8

57.6

57.0

0.20

148

1383

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

456

0.88

0.33

1.1

1.2

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

0.68

0.33

14.0

12.4

mmol/l

5.1

5.8

—

(3004616) Nuclear Ab [Presence] in Serum

740

1.10

0.32

1.4

1.3

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

351

3654

0.96

0.32

1.0

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

349

3350

1.04

0.32

2.4

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

389

1.13

0.31

1.4

1.5

u/l

11.1

6.4

0.44

335

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

522

1.11

0.31

1.8

1.6

—

(3025130) Human papilloma virus identified in Specimen

757

0.91

0.31

1.6

1.7

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

156

1.22

0.30

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

156

1.22

0.30

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

156

1.22

0.30

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

156

1.22

0.30

1.0

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

120

1.25

0.30

1.9

1.5

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

222

1.17

0.29

2.2

3.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

354

1.13

0.28

1.8

1.6

—

(3049717) Cytology report of Urine Cyto stain

252

2412

1.05

0.28

2.3

2.7

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

355

1.13

0.28

1.8

1.5

—

(3016750) Collection duration of Urine

375

0.88

0.27

2.3

2.2

min

490.4

492.0

0.02

277

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

459

0.89

0.27

1.0

1.1

iu/ml

11.6

9.6

—

109

(3006270) Folate [Moles/volume] in Blood

576

1.09

0.26

1.1

1.2

nmol/l

303.0

360.2

1.64

484

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

572

0.91

0.26

1.7

1.5

29.9

30.1

0.01

350

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

975

0.93

0.25

1.1

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.22

0.25

2.2

4.5

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

151

1589

0.95

0.24

1.4

1.3

u/ml

21.2

8.7

0.83

247

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

618

1.08

0.24

3.0

3.6

—

(3025577) Chromium [Mass/volume] in Blood

371

0.89

0.24

2.0

ug/l

4.5

2.4

0.40

310

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.28

0.24

1.2

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

115

1.22

0.23

6.6

7.5

—

(3010937) Rubella virus Ab [Presence] in Serum

1.32

0.23

1.0

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.28

0.23

1.2

1.3

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.28

0.23

1.0

1.2

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

307

2970

1.03

0.22

1.4

iu/l

31.4

25.9

1.77

249

2474

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

164

1715

0.96

0.22

1.3

1.2

u/ml

53.4

36.4

0.43

(3000012) Reticulocyte production index

347

0.89

0.22

2.0

1.4

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

124

0.81

0.21

1.0

1.3

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.3

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

0.21

0.0

1.2

—

36.4

—

(3020934) Sesame Seed IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

12.6

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.21

0.0

7.5

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.21

0.0

1.0

—

(40760512) CD34 cells/100 cells in Bone marrow

0.00

0.21

0.0

1.8

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.21

0.0

1.2

—

70.7

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

7.0

—

0.3

—

(3006969) Lambda light chains [Mass/volume] in Urine

0.00

0.21

0.0

1.1

—

0.0

—

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

0.00

0.21

0.0

7.9

—

60.6

—

(3000285) Sodium [Moles/volume] in Blood

1.24

0.20

1.1

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

150

1568

0.96

0.20

1.4

1.2

u/ml

4.9

5.6

0.09

151

(3027923) C peptide [Moles/volume] in Serum or Plasma

345

1.10

0.20

1.7

1.5

nmol/l

1.1

1.2

0.32

265

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

112

1063

1.05

0.20

1.5

1.3

u/l

66.3

39.9

0.59

928

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

365

0.90

0.19

1.2

1.3

—

(44813793)

491

1.08

0.19

1.1

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

222

1.13

0.19

4.6

6.2

—

(40768797) Stomach Pathology biopsy report

852

8655

0.98

0.19

1.2

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

155

1487

1.04

0.19

1.5

—

(3004775) Volume in Urine collected for unspecified duration

519

0.92

0.18

2.2

2.3

662.8

635.9

0.15

343

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.13

0.18

1.2

u/l

11.3

15.9

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

137

1.17

0.18

1.4

1.5

ug/l

0.3

0.4

—

(3005011) Chlamydia sp Ab [Titer] in Serum

109

1.19

0.18

1.4

1.5

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

123

1287

0.95

0.18

1.3

1.2

u/ml

1.6

4.3

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

529

5397

0.98

0.18

2.2

nmol/l

12.4

12.7

0.31

458

4749

(3016650) Hepatitis A virus Ab [Presence] in Serum

117

1117

1.05

0.17

1.1

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

1.21

0.17

2.7

1.9

pmol/l

122.5

41.9

0.55

(3041096) Erythrocytes [Presence] in Urine by Automated

1765

17476

1.01

0.17

4.1

3.2

—

(3047189) Immunofixation for 24 hour Urine

298

0.91

0.16

1.2

1.7

—

(3024471) HLA-A [Type]

244

1.11

0.16

1.0

—

(3000475) Leukocytes [#/volume] in Synovial fluid

155

1495

1.04

0.16

1.7

1.6

e6/l

12432.9

13780.1

0.21

110

1075

(3003327) Ova and parasites identified in Stool by Light microscopy

218

2244

0.97

0.15

1.6

1.8

—

(3001556) Androgen free Index in Serum or Plasma

0.78

0.15

1.2

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

140

0.86

0.15

5.4

6.2

—

(3044007) Cell count panel - Peritoneal fluid

178

1.12

0.15

1.5

2.0

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

371

1.08

0.15

6.4

6.7

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

138

1430

0.96

0.14

5.2

3.4

mg/l

28.1

26.8

0.15

897

(3029396) Erythrocyte agglutination [Presence] in Blood

171

0.88

0.14

3.7

2.9

—

(3022689) Creatine [Moles/volume] in Urine

188

1.12

0.14

1.7

1.5

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.18

0.14

1.1

1.2

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

285

0.91

0.14

1.2

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

282

2886

0.98

0.14

3.1

3.3

u/ml

147.9

54.7

0.42

272

2780

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

118

1136

1.04

0.14

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

160

1.12

0.14

1.3

1.1

—

(40768443) Skin Pathology biopsy report

284

2775

1.02

0.14

1.2

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

100

0.80

0.13

1.3

1.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

523

5146

1.02

0.13

1.5

1.4

—

(3036071) Salmonella sp Ab [Titer] in Serum

228

1.10

0.13

1.0

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

143

1476

0.97

0.13

1.2

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

106

0.85

0.13

1.1

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

104

1.15

0.12

1.9

1.6

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

498

0.94

0.12

1.6

1.7

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

487

0.94

0.12

1.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

191

1.10

0.11

1.3

1.2

g/l

40.5

38.7

—

106

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

486

0.95

0.11

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

486

0.95

0.11

1.1

—

(3024932) HLA-DR beta [Type]

240

1.08

0.11

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

153

1.11

0.11

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

136

0.88

0.11

1.0

1.1

—

(3048879) Bone marrow aspiration report

177

0.90

0.10

2.2

1.9

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

753

7605

0.99

0.10

4.1

4.4

32.2

0.04

550

5216

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

484

0.95

0.10

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

269

0.93

0.10

1.0

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

106

1.13

0.09

1.5

1.7

ng/l

90.4

144.0

1.32

106

(40759836) Histone Ab [Presence] in Serum by Immunoblot

483

0.95

0.09

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

483

0.95

0.09

1.1

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

143

1465

0.98

0.09

1.2

1.4

u/ml

265.3

258.6

0.12

880

(40768441) Liver Pathology biopsy report

487

1.05

0.09

1.5

—

(4015189)

155

0.90

0.09

1.4

2.2

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

6074

60622

1.01

0.09

18.5

13.0

ml/min/173m2

87.2

82.2

52.76

5159

49851

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

139

1357

1.02

0.08

1.5

1.6

u/ml

103.2

113.7

0.60

267

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

593

0.96

0.08

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

257

0.93

0.08

1.5

1.4

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

735

1.03

0.08

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

312

1.06

0.08

1.0

1.1

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

117

1.11

0.08

1.1

—

5.8

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.14

0.08

1.4

1.2

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

151

1541

0.98

0.08

1.2

1.3

—

(3043410) Blood group antigens tested for on Red Blood Cells

184

0.92

0.07

1.9

1.8

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

184

0.92

0.07

1.5

ug/l

10.8

8.7

0.63

184

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.04

0.07

1.0

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

0.82

0.07

19.9

9.0

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

154

1511

1.02

0.07

1.7

1.8

iu/l

3.5

4.6

1.30

545

(3045414) Leukocytes [Presence] in Urine

292

2883

1.01

0.07

1.8

1.9

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

734

7391

0.99

0.06

2.0

2.1

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

162

0.93

0.06

1.1

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

161

0.93

0.05

6.3

6.7

—

(3037556) Urate [Mass/volume] in Serum or Plasma

181

0.94

0.05

1.6

1.4

—

(3036603) Volume of Urine

413

0.97

0.04

1.7

1931.5

1882.6

—

100

(3042733) HLA Ab [Presence] in Serum

239

1.05

0.04

4.7

4.6

—

(3020650) Glucose [Presence] in Urine

170

0.94

0.04

1.1

1.4

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

247

2451

1.01

0.03

2.2

1.9

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

449

1.02

0.03

1.3

1.2

u/ml

38.7

12.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

227

2252

1.01

0.03

3.0

3.5

u/ml

178.6

2860.8

1.39

191

1919

(3006598) pH of Arterial cord blood

108

0.93

0.03

1.0

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

159

1576

1.01

0.02

2.5

2.4

ug/min

167.1

108.9

0.82

960

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1053

10507

1.00

0.02

1.6

—

(4133840)

187

0.96

0.01

1.4

1.2

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

568

0.99

0.01

1.3

mmol/l

8.9

11.7

1.66

143

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

472

1.02

0.01

1.3

1.2

u/ml

30.7

42.7

—

(3024263) Appearance of Synovial fluid

343

1.02

0.01

1.5

1.7

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

443

1.02

0.01

1.3

u/ml

0.2

1.0

1.59

182

(3002619) Bacteria identified in Specimen by Culture

136

0.96

0.00

1.2

—

(3000330) Specific gravity of Urine by Test strip

325

3255

1.00

0.00

4.1

3.4

—

(40758292) HTLV I+II Ab panel - Serum

115

1.04

0.00

1.5

1.4

—

(3009871) Measles virus Ab [Titer] in Serum

208

1.01

0.00

2.0

1.7

—

(44806420)

172

0.99

0.00

2.4

2.3

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

237

2373

1.00

0.00

1.2

1.3

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

208

2075

1.00

0.00

1.4

1.3

miu/ml

193.0

217.9

0.42

933

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

192

0.99

0.00

1.8

2.6

ng/l

286.5

117.0

0.47

129

(3051101) Glucose [Moles/volume] in Cord blood

106

1.04

0.00

6.6

6.9

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

605

0.99

0.00

1.2

1.4

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

488

1.00

0.00

1.2

1.3

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

180

1.00

0.00

6.3

6.6

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

135

1347

1.00

0.00

2.0

nmol/l

0.9

0.8

0.96

109

1127

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

147

1469

1.00

0.00

2.1

1.9

pmol/l

192.0

204.5

0.83

139

1386

(3001729) Color of Synovial fluid

0.86

0.00

1.0

1.5

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.0

1.0

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.0

1.1

—

117.8

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

5.3

—

(40759632) Porphyrins [Mass/mass] in Stool

0.00

0.0

1.2

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

0.0

1.0

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.95

0.00

1.1

1.2

—

(3027859) Formaldehyde IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3025315) Body weight

1.02

0.00

3.6

4.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

0.99

0.00

1.1

—

(3017497) Pine Nut IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

0.0

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

0.0

1.0

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.0

1.0

—

(3012932) Hazelnut IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

20.8

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.00

0.00

1.0

1.2

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3043614) Bacteria identified in Aspirate by Culture

0.00

0.0

1.0

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

0.0

1.1

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: FE_MODE – Focal epilepsy, mode (most common among epilepsy diagnosis)

GWS hits: -

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Focal epilepsy, mode (most common among epilepsy diagnosis)

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Focal epilepsy, mode (most common among epilepsy diagnosis) (FE_MODE)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints